Hanesbrands (HBI) 10-Q 30 Apr 20 2020 Q1 Quarterly report Financial data

Cover Page

Cover Page - shares	3 Months Ended
	Mar. 28, 2020	Apr. 24, 2020
Cover [Abstract]
Amendment Flag	false
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q1
Entity Central Index Key	0001359841
Current Fiscal Year End Date	--01-02
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 28, 2020
Document Transition Report	false
Entity File Number	001-32891
Entity Registrant Name	Hanesbrands Inc.
Entity Incorporation, State or Country Code	MD
Entity Tax Identification Number	20-3552316
Entity Address, Address Line One	1000 East Hanes Mill Road
Entity Address, City or Town	Winston-Salem,
Entity Address, State or Province	NC
Entity Address, Postal Zip Code	27105
City Area Code	336
Local Phone Number	519-8080
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Title of 12(b) Security	Common Stock, Par Value $0.01
Trading Symbol	HBI
Security Exchange Name	NYSE
Entity Common Stock, Shares Outstanding		348,035,310

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income (Unaudted) - USD ($) $ in Thousands	3 Months Ended
	Mar. 28, 2020	Mar. 30, 2019
Income Statement [Abstract]
Net sales	$ 1,316,462	$ 1,588,024
Cost of sales	842,730	967,993
Gross profit	473,732	620,031
Selling, general and administrative expenses	439,602	470,387
Operating profit	34,130	149,644
Other expenses	6,490	7,451
Interest expense, net	36,849	48,059
Income (loss) before income tax expense	(9,209)	94,134
Income tax expense (benefit)	(1,335)	13,046
Net income (loss)	$ (7,874)	$ 81,088
Earnings per share:
Basic	$ (0.02)	$ 0.22
Diluted	$ (0.02)	$ 0.22

Condensed Consolidated Statem_2

Condensed Consolidated Statement of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended
	Mar. 28, 2020	Mar. 30, 2019
Condensed Consolidated Statements Of Comprehensive Income (Unaudited) [Abstract]
Net income (loss)	$ (7,874)	$ 81,088
Other Comprehensive Income (Loss)
Translation adjustments	(117,154)	7,386
Unrealized gain (loss) on qualifying cash flow hedges, net of tax of $(7,280) and $1,658, respectively	7,783	(3,919)
Unrecognized income from pension and postretirement plans, net of tax of $(1,272) and $(1,205), respectively	3,594	3,397
Total other comprehensive income (loss)	(105,777)	6,864
Comprehensive income (loss)	$ (113,651)	$ 87,952

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Comprehensive Income (Loss) (Parenthetical) - USD ($) $ in Thousands	3 Months Ended
	Mar. 28, 2020	Mar. 30, 2019
Condensed Consolidated Statements Of Comprehensive Income (Unaudited) [Abstract]
Tax portion of unrealized gain (loss) on qualifying cash flow hedges	$ (7,280)	$ 1,658
Tax portion of unrecognized income from pension and postretirement plans	$ (1,272)	$ (1,205)

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Mar. 28, 2020	Dec. 28, 2019	Mar. 30, 2019
Assets
Cash and cash equivalents	$ 1,083,780	$ 328,876	$ 287,080
Trade accounts receivable, net	725,092	815,210	932,875
Inventories	1,963,757	1,905,845	2,232,719
Other current assets	178,244	174,634	189,012
Total current assets	3,950,873	3,224,565	3,641,686
Property, net	571,005	587,896	601,689
Right-of-use assets	473,936	487,787	484,453
Trademarks and other identifiable intangibles, net	1,435,356	1,520,800	1,547,718
Goodwill	1,205,195	1,235,711	1,240,652
Deferred tax assets	188,004	203,331	213,728
Other noncurrent assets	118,890	93,896	94,233
Total assets	7,943,259	7,353,986	7,824,159
Liabilities and Stockholders’ Equity
Accounts payable	925,417	959,006	1,007,420
Accrued liabilities	447,401	531,184	568,450
Lease liabilities	150,568	166,091	140,435
Notes payable	2,170	4,244	5,753
Accounts Receivable Securitization Facility	152,153	0	200,000
Current portion of long-term debt	111,359	110,914	276,815
Total current liabilities	1,789,068	1,771,439	2,198,873
Long-term debt	4,236,955	3,256,870	3,615,493
Lease liabilities - noncurrent	358,848	358,281	373,365
Pension and postretirement benefits	375,511	403,458	352,069
Other noncurrent liabilities	309,306	327,343	351,368
Total liabilities	7,069,688	6,117,391	6,891,168
Stockholders’ equity:
Preferred stock (50,000,000 authorized shares; $.01 par value) Issued and outstanding - None	0	0	0
Common stock (2,000,000,000 authorized shares; $.01 par value) Issued and outstanding - 348,035,310, 362,449,307, and 361,471,010, respectively	3,480	3,624	3,615
Additional paid-in capital	297,456	304,395	306,084
Retained earnings	1,296,060	1,546,224	1,191,111
Accumulated other comprehensive loss	(723,425)	(617,648)	(567,819)
Total stockholders’ equity	873,571	1,236,595	932,991
Total liabilities and stockholders’ equity	$ 7,943,259	$ 7,353,986	$ 7,824,159

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 28, 2020	Dec. 28, 2019	Mar. 30, 2019
Statement of Financial Position [Abstract]
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01	$ 0.01
Preferred stock, shares authorized	50,000,000	50,000,000	50,000,000
Preferred stock, shares issued	0	0	0
Preferred stock, shares outstanding	0	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01	$ 0.01
Common stock, shares authorized	2,000,000,000	2,000,000,000	2,000,000,000
Common stock, shares issued	348,035,310	362,449,037	361,471,010
Common stock, shares outstanding	348,035,310	362,449,037	361,471,010

Condensed Consolidated Statem_4

Condensed Consolidated Statement of Stockholders' Equity Statement - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Loss
Beginning Balance at Dec. 29, 2018	$ 872,126	$ 3,613	$ 284,877	$ 1,079,503	$ (495,867)
Beginning Balance, Shares at Dec. 29, 2018		361,330,000
Net income (loss)	81,088			81,088
Dividends ($0.15 per common share)	$ (54,852)			(54,852)
Dividends, per share	$ 0.15
Other comprehensive income (loss)	$ 6,864				6,864
Stock-based compensation	5,057		5,057
Net exercise of stock options, vesting of restricted stock units and other, shares		141,000
Net exercise of stock options, vesting of restricted stock units and other	1,778	$ 2	1,776
Modification of deferred compensation plans	14,374		14,374
Cumulative effect of change in adoption of leases standard	6,556			6,556
Stranded tax related to U.S. pension plan	0			78,816	(78,816)
Ending Balance at Mar. 30, 2019	$ 932,991	$ 3,615	306,084	1,191,111	(567,819)
Ending Balance, Shares at Mar. 30, 2019	361,471,010	361,471,000
Beginning Balance at Dec. 29, 2018	$ 872,126	$ 3,613	284,877	1,079,503	(495,867)
Beginning Balance, Shares at Dec. 29, 2018		361,330,000
Beginning Balance at Dec. 29, 2018	872,126	$ 3,613	284,877	1,079,503	(495,867)
Beginning Balance, Shares at Dec. 29, 2018		361,330,000
Beginning Balance at Mar. 30, 2019	$ 932,991	$ 3,615	306,084	1,191,111	(567,819)
Beginning Balance, Shares at Mar. 30, 2019	361,471,010	361,471,000
Beginning Balance at Dec. 28, 2019	$ 1,236,595	$ 3,624	304,395	1,546,224	(617,648)
Beginning Balance, Shares at Dec. 28, 2019	362,449,037	362,449,000
Net income (loss)	$ (7,874)			(7,874)
Dividends ($0.15 per common share)	$ (54,421)			(54,421)
Dividends, per share	$ 0.15
Other comprehensive income (loss)	$ (105,777)				(105,777)
Stock-based compensation	4,641		4,641
Net exercise of stock options, vesting of restricted stock units and other, shares		50,000
Net exercise of stock options, vesting of restricted stock units and other	676	$ 1	675
Share repurchases, shares		(14,464,000)
Share repurchases	(200,269)	$ (145)	(12,255)	(187,869)
Ending Balance at Mar. 28, 2020	$ 873,571	$ 3,480	$ 297,456	$ 1,296,060	$ (723,425)
Ending Balance, Shares at Mar. 28, 2020	348,035,310	348,035,000

Condensed Consolidated Statem_5

Condensed Consolidated Statement of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 28, 2020	Mar. 30, 2019	Dec. 28, 2019
Operating activities:
Net income (loss)	$ (7,874)	$ 81,088
Adjustments to reconcile net income (loss) to net cash from operating activities:
Depreciation	22,781	22,854
Amortization of acquisition intangibles	6,113	6,290
Other amortization	2,477	3,090
Amortization of debt issuance costs	2,123	2,440
Stock compensation expense	4,723	5,178
Deferred taxes	(461)	(3,854)
Other	(9,520)	4,247
Changes in assets and liabilities:
Accounts receivable	73,694	(62,278)
Inventories	(86,785)	(178,405)
Other assets	26,790	(32,372)
Accounts payable	(13,605)	(18,213)
Accrued pension and postretirement benefits	(21,481)	(21,978)
Accrued liabilities and other	(82,191)	(2,378)
Net cash from operating activities	(83,216)	(194,291)
Investing activities:
Capital expenditures	(25,759)	(25,269)
Proceeds from sales of assets	66	136
Other	(1,216)	0
Net cash from investing activities	(24,477)	(25,133)
Financing activities:
Borrowings on notes payable	62,312	82,774
Repayments on notes payable	(64,352)	(82,759)
Borrowings on Accounts Receivable Securitization Facility	227,061	106,942
Repayments on Accounts Receivable Securitization Facility	(74,909)	(68,550)
Borrowings on Revolving Loan Facilities	1,638,000	772,500
Repayments on Revolving Loan Facilities	(688,000)	(680,500)
Repayments on Term Loan Facilities	0	(10,625)
Borrowings on International Debt	31,222	7,141
Share repurchases	(200,269)	0
Cash dividends paid	(53,683)	(54,221)
Payments to amend and refinance credit facilities	(232)	(662)
Taxes paid related to net shares settlement of equity awards	(62)	(906)
Other	426	573
Net cash from financing activities	877,514	71,707
Effect of changes in foreign exchange rates on cash	(15,061)	2,104
Change in cash, cash equivalents and restricted cash	754,760	(145,613)
Cash, cash equivalents and restricted cash at beginning of year	329,923	455,732	$ 455,732
Cash, cash equivalents and restricted cash at end of period	1,084,683	310,119	329,923
Less restricted cash at end of period	903	23,039
Cash and cash equivalents per balance sheet at end of period	1,083,780	287,080	328,876
Capital expenditures included in accounts payable	12,807		$ 19,327
Right-of-Use assets obtained in exchange for lease obligations	$ 17,551	$ 6,192

Basis of Presentation

Basis of Presentation	3 Months Ended
	Mar. 28, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation These statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) and, in accordance with those rules and regulations, do not include all information and footnote disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). Management believes that the disclosures made are adequate for a fair statement of the results of operations, financial condition and cash flows of Hanesbrands Inc. and its consolidated subsidiaries (the “Company” or “Hanesbrands”). In the opinion of management, the condensed consolidated interim financial statements reflect all adjustments, which consist only of normal recurring adjustments, necessary to state fairly the results of operations, financial condition and cash flows for the interim periods presented herein. The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make use of estimates and assumptions that affect the reported amounts and disclosures. Actual results may vary from these estimates. These condensed consolidated interim financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s 2019 Annual Report on Form 10-K. The year-end condensed balance sheet data was derived from audited financial statements, but does not include all disclosures required by GAAP. The results of operations for any interim period are not necessarily indicative of the results of operations to be expected for the full year. Liquidity and Impact of COVID-19 The Company relies on its cash flows generated from operations and the borrowing capacity under its credit facilities to meet the cash requirements of its business. The primary cash requirements of its business are payments to employees and vendors in the normal course of business, capital expenditures, maturities of debt and related interest payments, business acquisitions, contributions to its pension plans, repurchases of its stock, regular quarterly dividend payments and income tax payments. The rapid expansion of the COVID-19 global pandemic has resulted in a sharp decline in net sales and earnings in the first quarter of 2020, which has a corresponding impact on the Company’s liquidity. The Company is focused on preserving its liquidity and managing its cash flow during these unprecedented conditions with preemptive actions to enhance its ability to meet its short-term liquidity needs. Such actions include, but are not limited to, operating manufacturing and distribution facilities on a demand-adjusted basis; reducing discretionary spending such as media and marketing expenses; focused working capital management; reducing capital expenditures; suspending its share buyback program until further notice; reducing payroll costs, through employee furloughs and pay cuts; drawing down on its Revolving Loan Facility and amending certain existing debt facilities. In March 2020, in response to the uncertainty of the circumstances surrounding the COVID-19 global pandemic, the Company drew down $630,000 under the Revolving Loan Facility as a precautionary measure, to provide the Company with additional financial flexibility to manage its business with a safety-first emphasis during the unknown duration and impact of the COVID-19 global pandemic. The Company subsequently repaid $490,000 of its borrowings under the Revolving Loan Facility in April 2020. As of March 28, 2020 , the Company was in compliance with all financial covenants under its credit facilities and other outstanding indebtedness. In April 2020, given the rapidly changing environment and level of uncertainty being created by the COVID-19 global pandemic and the associated impact on future earnings, the Company amended its Senior Secured Credit Facility (as discussed in Note, “Debt and Notes Payable”) prior to any potential covenant violation in order to modify the financial covenants and to provide operating flexibility during the COVID-19 crisis. After obtaining the debt amendment, which provides relief from certain covenants for a 15-month period and adds additional financial and non-financial covenants, the Company expects to maintain compliance with its covenants for at least one year from the issuance of these financial statements based on its current expectations and forecasts. If economic conditions caused by the COVID-19 global pandemic worsen and the Company’s earnings and operating cash flows do not start to recover as currently estimated by management, this could impact the Company’s ability to maintain compliance with its amended financial covenants and require the Company to seek additional amendments to its Senior Secured Credit Facility. If the Company is not able to obtain such necessary additional amendments, this would lead to an event of default and, if not cured timely, its lenders could require the Company to repay its outstanding debt. In that situation, the Company may not be able to raise sufficient debt or equity capital, or divest assets, to refinance or repay the lenders. Revisions of Previously Issued Consolidated Financial Statements As previously disclosed in the Company's Annual Report on Form 10-K for the year ended December 28, 2019, during the fourth quarter of 2019 the Company identified tax errors, which originated prior to 2017, in its previously issued 2018 and 2017 annual consolidated financial statements and quarterly condensed consolidated interim financial statements for each of the quarterly periods of 2018 and the first three quarterly periods of 2019. Although the Company assessed the materiality of the errors and concluded that the errors were not material to the previously issued annual or interim financial statements, the Company did revise its previously issued 2018 and 2017 annual financial statements to correct for such tax errors in connection with the filing of its 2019 Annual Report on Form 10-K, and disclosed that it would be revising its 2019 condensed consolidated interim financial statements in connection with the filing of its Quarterly Reports on Form 10-Q during 2020. In connection with such revision, the Company also corrected for certain other immaterial errors. In connection with the filing of this Quarterly Report on Form 10-Q, the Company has revised the accompanying condensed consolidated interim financial statements as of and for the quarter ended March 30, 2019 to correct for the impact of such errors, including the impact to retained earnings as of March 30, 2019 to correct for the errors which originated in periods prior to 2019, which primarily related to the tax errors. The accompanying footnotes have also been corrected to reflect the impact of the revisions of the previously filed condensed consolidated interim financial statements.

Recent Accounting Pronouncement

Recent Accounting Pronouncements	3 Months Ended
	Mar. 28, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Recent Accounting Pronouncements	Recent Accounting Pronouncements Financial Instruments - Credit Losses In June 2016, the Financial Accounting Standards Board (“FASB”) issued ASU 2016-13, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,” which requires a financial asset measured at amortized cost basis to be presented at the net amount expected to be collected. The new accounting rules eliminate the probable initial recognition threshold and, instead, reflect an entity’s current estimate of all expected credit losses. The new accounting rules were effective for the Company in the first quarter of 2020 and applies to its trade receivables. Under the new accounting rules, trade receivables are now evaluated on a collective (pool) basis and aggregated on the basis of similar risk characteristics. These classifications will be reassessed at each measurement date. A combination of factors, such as industry trends, customers’ financial strength, credit standing and payment and default history are considered in determining the appropriate estimate of expected credit losses. The adoption of the new accounting rules did not have a material impact on the Company’s financial condition, results of operations or cash flows. Goodwill Impairment In January 2017, the FASB issued ASU 2017-04, “Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment.” The new accounting rules simplify how an entity is required to test goodwill for impairment by eliminating Step 2 from the goodwill impairment test which previously measured a goodwill impairment loss by comparing the implied fair value of a reporting unit’s goodwill with the carrying amount. The new accounting rules were effective for the Company in the first quarter of 2020. As a result of adopting the new rules, the Company will compare the estimated fair value of its reporting units to their respective carrying values when evaluating the recoverability of goodwill. If the carrying value of a reporting unit exceeds its fair value, an impairment charge will be recognized for the amount by which its carrying value exceeds the reporting unit’s fair value; however, the loss recognized will not exceed the goodwill allocated to the reporting unit. The adoption of the new accounting rules did not have an impact on the Company’s financial condition, results of operations or cash flows. Fair Value In August 2018, the FASB issued ASU 2018-13, “Fair Value Measurement (Topic 820),” which modifies the disclosure requirements on fair value measurements. The new accounting rules were effective for the Company in the first quarter of 2020. The adoption of the new accounting rules did not have a material impact on the Company’s financial condition, results of operations or cash flows; however, its disclosures were updated upon adoption. Retirement Benefits In August 2018, the FASB issued ASU 2018-14, “Compensation - Retirement Benefits - Defined Benefit Plans - General (Subtopic 715-20).” The new accounting rules expand disclosure requirements for employer sponsored defined benefit pension and other retirement plans. The new accounting rules were effective for the Company in the first quarter of 2020. The new accounting rules did not have a material impact on the Company’s financial condition, results of operations or cash flows; however, expanded disclosures will be required on the Company’s Annual Report on Form 10-K for the year ended January 2, 2021. Internal-Use Software In August 2018, the FASB issued ASU 2018-15, “Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 340-40),” which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The new accounting rules were effective for the Company in the first quarter of 2020. The adoption of the new accounting rules did not have a material impact on the Company’s financial condition, results of operations or cash flows. Codification Improvements to Financial Instruments In March 2020, the FASB issued ASU 2020-03, “Codification Improvements to Financial Instruments.” The new accounting rules clarify guidance around several subtopics by adopting enhanced verbiage to the following subtopics: fair value option disclosures, fair value measurement, investments - debt and equities securities, debt modifications and extinguishments, credit losses, and sales of financial assets. The standard was effective for the Company in the first quarter of 2020. The adoption of the new accounting rules did not have a material impact on the Company’s results of operations or cash flows. Income Taxes In December 2019, the FASB issued ASU 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.” The new accounting rules reduce complexity by removing specific exceptions to general principles related to intraperiod tax allocations, ownership changes in foreign investments, and interim period income tax accounting for year-to-date losses that exceed anticipated losses. The new accounting rules also simplify accounting for franchise taxes that are partially based on income, transactions with a government that result in a step up in the tax basis of goodwill, separate financial statements of legal entities that are not subject to tax, and enacted changes in tax laws in interim periods. The new accounting rules will be effective for the Company in the first quarter of 2021. The Company is currently in the process of evaluating the impact of adoption of the new accounting rules on the Company’s financial condition, results of operations, cash flows and disclosures. Reference Rate Reform In March 2020, the FASB issued ASU 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” The new accounting rules provide optional expedients and exceptions for applying generally accepted accounting principles to contracts, hedging relationships, and other transactions affected by reference rate reform. The amendments in this standard can be applied anytime between the first quarter of 2020 and the fourth quarter of 2022. The Company is currently in the process of evaluating the impact of adoption of the new rules on the Company’s financial condition, results of operations, cash flows and disclosures.

Revenue Recognition

Revenue Recognition	3 Months Ended
	Mar. 28, 2020
Revenue from Contract with Customer [Abstract]
Revenue Recognition	Revenue Recognition Revenue is recognized when obligations under the terms of a contract with a customer are satisfied, which occurs at a point in time, upon either shipment or delivery to the customer. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods, which includes estimates for variable consideration. Variable consideration includes trade discounts, rebates, volume-based incentives, cooperative advertising and product returns, which are offered within contracts between the Company and its customers, employing the practical expedient for contract costs. Incidental items that are immaterial to the context of the contract are recognized as expense at the transaction date. The following table presents the Company’s revenues disaggregated by the customer’s method of purchase: Quarters Ended March 28, March 30, Third-party brick-and-mortar wholesale $ 978,127 $ 1,231,423 Consumer-directed 338,335 356,601 Total net sales $ 1,316,462 $ 1,588,024 Revenue Sources Third-Party Brick-and-Mortar Wholesale Revenue Third-party brick-and-mortar wholesale revenue is primarily generated by sales of the Company’s products to retailers to support their brick-and-mortar operations. Also included within third-party brick-and-mortar wholesale revenues is royalty revenue from licensing agreements. The Company earns royalties through license agreements with manufacturers of other consumer products that incorporate certain of the Company’s brands. The Company accrues revenue earned under these contracts based upon reported sales from the licensees. Consumer-Directed Revenue

Acquisitions

Acquisitions	3 Months Ended
	Mar. 28, 2020
Business Combinations [Abstract]
Acquisitions	Acquisitions Bras N Things On February 12, 2018, the Company acquired 100% of the outstanding equity of BNT Holdco Pty Limited (“Bras N Things”) for a total purchase price of A $498,236 (U.S. $391,572 ). During 2018, due to the final working capital adjustment, the purchase consideration was reduced by A$3,012 (U.S. $2,367 ), ultimately resulting in a revised purchase price of A$495,224 (U.S. $389,205 ), which included a cash payment of A $428,956 (U.S. $337,123 ), an indemnification escrow of A $31,988 (U.S. $25,140 ) and debt assumed of A $34,280 (U.S. $26,942 ). U.S. dollar equivalents are based on acquisition date exchange rates. The Company funded the acquisition with a combination of short-term borrowings under its existing revolving loan facility (the “Revolving Loan Facility”) and cash on hand. During the third quarter of 2019, A $31,425 (U.S. $21,360 ) of the indemnification escrow, including interest earned, was paid to the sellers. The remaining indemnification escrow, held in one of the Company’s bank accounts, is recognized and classified as restricted cash, with the balance as of March 28, 2020 included in the “Other current assets” line of the Condensed Consolidated Balance Sheet. Since February 12, 2018, goodwill related to the Bras N Things acquisition decreased by $792 as a result of measurement period adjustments, primarily related to working capital adjustments. The purchase price allocation was finalized in the first quarter of 2019.

Stockholders' Equity

Stockholders' Equity	3 Months Ended
	Mar. 28, 2020
Text Block [Abstract]
Stockholders' Equity	Stockholders’ Equity Basic earnings per share (“EPS”) was computed by dividing net income by the number of weighted average shares of common stock outstanding during the period. Diluted EPS was calculated to give effect to all potentially issuable dilutive shares of common stock using the treasury stock method. The reconciliation of basic to diluted weighted average shares outstanding is as follows: Quarters Ended March 28, March 30, Basic weighted average shares outstanding 359,017 364,570 Effect of potentially dilutive securities: Stock options — 471 Restricted stock units — 254 Employee stock purchase plan and other — 4 Diluted weighted average shares outstanding 359,017 365,299 For the quarter ended March 28, 2020, all potentially dilutive securities were excluded from the diluted earnings per share calculation because the Company incurred a net loss for this period and their inclusion would be anti-dilutive. Anti-dilutive securities excluded from the diluted earnings per share calculation for the quarter ended March 28, 2020 are not material. For the quarter ended March 30, 2019 , restricted stock units totaling five were excluded from the diluted earnings per share calculation because their effect would be anti-dilutive. For the quarter ended March 30, 2019 , there were no anti-dilutive stock options to purchase shares of common stock. On February 6, 2020 , the Company’s Board of Directors approved a new share repurchase program for up to 40,000 shares to be repurchased in open market transactions, subject to market conditions, legal requirements and other factors. Additionally, management has been granted authority to establish a trading plan under Rule 10b5-1 of the Exchange Act in connection with share repurchases, which will allow the Company to repurchase shares in the open market during periods in which the stock trading window is otherwise closed for the Company and certain of the Company’s officers and employees pursuant to the Company’s insider trading policy. Unless terminated earlier by the Company’s Board of Directors, the new program will expire when the Company has repurchased all shares authorized for repurchase under the new program. The new program replaced the Company’s previous share repurchase program for up to 40,000 shares that was originally approved in 2016. For the quarter ended March 28, 2020 , the Company entered into transactions to repurchase 14,464 shares at a weighted average repurchase price of $13.83 per share under the new program. The shares were repurchased at a total cost of $200,269 . The Company did not repurchase any shares under the previous share repurchase program during the quarter ended March 28, 2020 or March 30, 2019 . At March 28, 2020 , the remaining repurchase authorization under the current share repurchase program totaled 25,536 shares. The primary objective of the share repurchase program is to utilize excess cash to generate shareholder value.

Inventories

Inventories	3 Months Ended
	Mar. 28, 2020
Inventory Disclosure [Abstract]
Inventories	Inventories Inventories consisted of the following: March 28, December 28, March 30, Raw materials $ 89,558 $ 83,545 $ 118,824 Work in process 124,725 136,592 170,746 Finished goods 1,749,474 1,685,708 1,943,149 $ 1,963,757 $ 1,905,845 $ 2,232,719

Debt

Debt	3 Months Ended
	Mar. 28, 2020
Debt Disclosure [Abstract]
Debt	Debt and Notes Payable Debt and notes payable consisted of the following: Interest Principal Amount Maturity Date March 28, December 28, Senior Secured Credit Facility: Revolving Loan Facility 1.91% $ 950,000 $ — December 2022 Term Loan A 1.89% 625,000 625,000 December 2022 Term Loan B 3.35% 300,000 300,000 December 2024 Australian Revolving Loan Facility 1.67% 30,817 — July 2021 4.875% Senior Notes 4.88% 900,000 900,000 May 2026 4.625% Senior Notes 4.63% 900,000 900,000 May 2024 3.5% Senior Notes 3.50% 556,793 558,847 June 2024 European Revolving Loan Facility 1.50% 111,359 110,914 September 2020 Accounts Receivable Securitization Facility 2.20% 152,153 — March 2021 Total debt 4,526,122 3,394,761 Notes payable 2,170 4,244 Total debt and notes payable 4,528,292 3,399,005 Less long-term debt issuance costs 25,655 26,977 Less notes payable 2,170 4,244 Less current maturities 263,512 110,914 Total long-term debt $ 4,236,955 $ 3,256,870 As of March 28, 2020 , the Company had $45,924 of borrowing availability under the $1,000,000 Revolving Loan Facility after taking into account $4,076 of standby and trade letters of credit issued and outstanding under this facility. In March 2020, in response to the uncertainty of the circumstances surrounding the COVID-19 global pandemic, the Company drew down $630,000 under the Revolving Loan Facility as a precautionary measure to provide the Company with additional financial flexibility to manage its business with a safety-first emphasis during the unknown duration and impact of the COVID-19 global pandemic. The Company subsequently repaid $490,000 of its borrowings under the Revolving Loan Facility in April 2020. The Company entered into an accounts receivable securitization facility (the “Accounts Receivable Securitization Facility”) in November 2007. The Company’s maximum borrowing capacity under the Accounts Receivable Securitization Facility was $175,000 as of March 28, 2020 . Borrowings under the Accounts Receivable Securitization Facility are permitted only to the extent that the face of the receivables in the collateral pool, net of applicable reserves and other deductions, exceeds the outstanding loans and also subject to a fluctuating facility limit, not to exceed $225,000 . The Company had no borrowing availability under the Accounts Receivable Securitization Facility at March 28, 2020 . The Company had $5,958 of borrowing availability under the Australian Revolving Loan Facility, no borrowing availability under the European Revolving Loan Facility and $134,716 of borrowing availability under other international credit facilities after taking into account outstanding borrowings and letters of credit outstanding under the applicable facilities at March 28, 2020 . In March 2020, the Company amended the Accounts Receivable Securitization Facility. This amendment primarily decreased the fluctuating facility limit to $225,000 (previously $300,000 ) and extended the maturity date to March 2021 . As of March 28, 2020 , the Company was in compliance with all financial covenants under its credit facilities and other outstanding indebtedness. The Company continues to monitor its covenant compliance carefully. Under the terms of its Senior Secured Credit Facility, among other financial and non-financial covenants, the Company is required to maintain a minimum interest coverage ratio and a maximum leverage ratio. The interest coverage ratio covenant is the ratio of the Company’s EBITDA for the preceding four fiscal quarters to its consolidated total interest expense and the maximum leverage ratio covenant is the ratio of the Company’s total debt to EBITDA for the preceding four fiscal quarters. EBITDA is defined as earnings before interest, income taxes, depreciation expense and amortization, as computed pursuant to the Senior Secured Credit Facility. In April 2020, given the rapidly changing environment and level of uncertainty being created by the COVID-19 global pandemic and the associated impact on future earnings, the Company amended its Senior Secured Credit Facility prior to any potential covenant violation in order to modify the financial covenants and to provide operating flexibility during the COVID-19 crisis. The amendment effects changes to certain provisions and covenants under the Senior Secured Credit Facility during the period beginning with the fiscal quarter ending June 27, 2020 and continuing through the fiscal quarter ending July 3, 2021 (such period of time, the “Covenant Relief Period”), including: (a) suspension of compliance with the maximum leverage ratio; (b) reduction of the minimum interest coverage ratio from 3.00 to 1.00 to (i) 2.00 to 1.00 for the fiscal quarters ending June 27, 2020 through April 3, 2021 and (ii) 2.25 to 1.00 for the fiscal quarter ending July 3, 2021; (c) a minimum last twelve months EBITDA covenant of $625,000 as of June 27, 2020, $505,000 as of September 26, 2020, $445,000 as of January 2, 2021, $435,000 as of April 3, 2021 and $505,000 as of July 3, 2021; (d) a minimum liquidity covenant of $300,000 , increasing to $400,000 upon certain conditions; (e) increased limitations on investments, acquisitions, restricted payments and the incurrence of indebtedness; and (f) anti-cash hoarding provisions. During the Covenant Relief Period, the applicable margin and applicable commitment fee margin will be calculated assuming the leverage ratio is greater than or equal to 4.50 to 1.00. The amendment also permanently amends the definition of “leverage ratio” for purposes of the financial covenant calculation to remove the maximum amount of cash allowed to be netted from the definition of “indebtedness” and to allow for the netting of cash from certain foreign subsidiaries. After obtaining the debt amendment, the Company expects to maintain compliance with its covenants for at least one year from the issuance of these financial statements based on its current expectations and forecasts. If economic conditions caused by the COVID-19 global pandemic worsen and the Company’s earnings and operating cash flows do not start to recover as currently estimated by management, this could impact the Company’s ability to maintain compliance with its amended financial covenants and require the Company to seek additional amendments to its Senior Secured Credit Facility. If the Company is not able to obtain such necessary additional amendments, this would lead to an event of default and, if not cured timely, its lenders could require the Company to repay its outstanding debt. In that situation, the Company may not be able to raise sufficient debt or equity capital, or divest assets, to refinance or repay the lenders.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss	3 Months Ended
	Mar. 28, 2020
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Accumulated Other Comprehensive Loss	Accumulated Other Comprehensive Loss The components of accumulated other comprehensive loss (“AOCI”) are as follows: Cumulative Translation Adjustment (1) Cash Flow Hedges Defined Benefit Plans Income Taxes Accumulated Other Comprehensive Loss Balance at December 28, 2019 $ (157,138 ) $ 4,786 $ (629,360 ) $ 164,064 $ (617,648 ) Amounts reclassified from accumulated other comprehensive loss — (5,017 ) 4,866 — (151 ) Current-period other comprehensive income (loss) activity (117,154 ) 20,080 — (8,552 ) (105,626 ) Balance at March 28, 2020 $ (274,292 ) $ 19,849 $ (624,494 ) $ 155,512 $ (723,425 ) (1) Cumulative Translation Adjustment includes translation adjustments and net investment hedges. See Note, “Financial Instruments and Risk Management” for additional disclosures about net investment hedges. The Company had the following reclassifications out of AOCI: Component of AOCI Location of Reclassification into Income Amount of Reclassification from AOCI Quarters Ended March 28, March 30, Gain on foreign exchange contracts designated as cash flow hedges Cost of sales $ 5,017 $ 6,017 Income tax (1,272 ) (1,521 ) Net of tax 3,745 4,496 Amortization of deferred actuarial loss and prior service cost Other expenses (4,866 ) (4,602 ) Income tax 1,272 1,205 Net of tax (3,594 ) (3,397 ) Total reclassifications $ 151 $ 1,099

Financial Instruments and Risk

Financial Instruments and Risk Management	3 Months Ended
	Mar. 28, 2020
Text Block [Abstract]
Financial Instruments and Risk Management	Financial Instruments and Risk Management The Company uses forward foreign exchange contracts to manage its exposures to movements in foreign exchange rates. The Company also uses a combination of derivative instruments and long-term debt to manage its exposure to foreign currency risk associated with the Company’s net investment in its European subsidiaries. As of March 28, 2020 , the notional U.S. dollar equivalent of the Company’s derivative portfolio of forward foreign exchange contracts was $553,575 , consisting of contracts hedging exposures primarily related to the Euro, Australian dollar, Canadian dollar and Mexican peso. As of March 28, 2020 , the U.S. dollar equivalent carrying value of long-term debt designated as a partial European net investment hedge was $556,793 . The notional U.S. dollar equivalent of the Company’s cross-currency swap contracts, which are also designated as partial European net investment hedges, was $335,940 as of March 28, 2020 . Fair Values of Derivative Instruments The fair values of derivative financial instruments related to forward foreign exchange contracts and cross-currency swap contracts recognized in the Condensed Consolidated Balance Sheets of the Company were as follows: Balance Sheet Location Fair Value March 28, December 28, Derivatives designated as hedging instruments: Forward foreign exchange contracts Other current assets $ 17,312 $ 2,716 Cross-currency swap contracts Other current assets 2,873 926 Cross-currency swap contracts Other noncurrent assets 18,868 2,975 Derivatives not designated as hedging instruments: Forward foreign exchange contracts Other current assets 15,747 5,314 Total derivative assets 54,800 11,931 Derivatives designated as hedging instruments: Forward foreign exchange contracts Accrued liabilities (6 ) (2,246 ) Derivatives not designated as hedging instruments: Forward foreign exchange contracts Accrued liabilities (3,263 ) (1,147 ) Total derivative liabilities (3,269 ) (3,393 ) Net derivative asset $ 51,531 $ 8,538 Cash Flow Hedges The Company uses forward foreign exchange contracts to reduce the effect of fluctuating foreign currencies on short-term foreign currency-denominated transactions, foreign currency-denominated investments and other known foreign currency exposures. Gains and losses on these contracts are intended to offset losses and gains on the hedged transaction in an effort to reduce the earnings volatility resulting from fluctuating foreign currency exchange rates. The Company expects to reclassify into earnings during the next 12 months a net gain from AOCI of approximately $21,396 . The Company is hedging exposure to the variability in future cash flows for forecasted transactions over the next 14 months. The effect of cash flow hedge derivative instruments on the Condensed Consolidated Statements of Income and AOCI is as follows: Amount of Gain Recognized in AOCI on Derivative Instruments Quarters Ended March 28, March 30, Foreign exchange contracts $ 20,080 $ 440 Location of Gain Amount of Gain Reclassified from AOCI into Income Quarters Ended March 28, March 30, Foreign exchange contracts (1) Cost of sales $ 5,017 $ 6,017 (1) The Company does not exclude amounts from effectiveness testing for cash flow hedges that would require recognition into earnings based on changes in fair value. Quarters Ended March 28, March 30, Total cost of sales in which the effects of cash flow hedges are recorded $ 842,730 $ 967,993 Net Investment Hedges In July 2019, the Company entered into two pay-fixed rate, receive-fixed rate cross-currency swap contracts with a total notional amount of €300,000 that were designated as hedges of a portion of the beginning balance of the Company’s net investment in its European subsidiaries. These cross-currency swap contracts, which mature on May 15, 2024, swap U.S. dollar-denominated interest payments for Euro-denominated interest payments, thereby economically converting a portion of the Company’s fixed-rate 4.625% Senior Notes to a fixed-rate 2.3215% Euro-denominated obligation. In July 2019, the Company also designated its 3.5% Senior Notes with a carrying value of €500,000 , which is a nonderivative financial instrument, as a hedge of a portion of the beginning balance of the Company’s European net investment. The amount of after-tax gains included in AOCI in the Condensed Consolidated Balance Sheets related to derivative instruments and nonderivative financial instruments designated as net investment hedges and the amount of gains included in the “Interest expense, net” line in the Condensed Consolidated Statements of Income related to amounts excluded from the assessment of hedge effectiveness for derivative instruments designated as net investment hedges are as follows: Amount of Gain Recognized in AOCI Quarters Ended March 28, March 30, Euro-denominated long-term debt $ 2,658 $ — Cross-currency swap contracts 11,732 — Total $ 14,390 $ — Location of Gain Recognized in Income Amount of Gain Recognized in Income Quarters Ended March 28, March 30, Cross-currency swap contracts Interest expense, net $ 1,947 $ — Quarters Ended March 28, March 30, Total interest expense, net in which the amounts excluded from effectiveness testing for net investment hedges are recorded $ 36,849 $ 48,059 Mark to Market Hedges A derivative used as a hedging instrument whose change in fair value is recognized to act as a hedge against changes in the values of the hedged item is designated as a mark to market hedge. The Company uses foreign exchange derivative contracts as hedges against the impact of foreign exchange fluctuations on existing accounts receivable and payable balances and intercompany lending transactions denominated in foreign currencies. Foreign exchange derivative contracts are recorded as mark to market hedges when the hedged item is a recorded asset or liability that is revalued in each accounting period. These contracts are not designated as hedges under the accounting standards and are recorded at fair value in the Condensed Consolidated Balance Sheets. Any gains or losses resulting from changes in fair value are recognized directly into earnings. Gains or losses on these contracts largely offset the net remeasurement gains or losses on the related assets and liabilities. The effect of derivative contracts not designated as hedges on the Condensed Consolidated Statements of Income is as follows: Location of Gain (Loss) Amount of Gain (Loss) Recognized in Income Quarters Ended March 28, March 30, Foreign exchange contracts Cost of sales $ 6,121 $ (9,397 ) Foreign exchange contracts Selling, general and administrative expenses (1,031 ) (659 ) Total $ 5,090 $ (10,056 )

Fair Value of Assets and Liabil

Fair Value of Assets and Liabilities	3 Months Ended
	Mar. 28, 2020
Text Block [Abstract]
Fair Value of Assets and Liabilities	Fair Value of Assets and Liabilities As of March 28, 2020 , the Company held certain financial assets and liabilities that are required to be measured at fair value on a recurring basis. These consisted of the Company’s derivative instruments related to forward foreign exchange derivative contracts, cross-currency swap derivative contracts and deferred compensation plan liabilities. The fair values of forward foreign exchange derivative contracts are determined using the cash flows of the forward contracts, discount rates to account for the passage of time and current foreign exchange market data which are all based on inputs readily available in public markets and are categorized as Level 2. The fair values of cross-currency swap derivative contracts are determined using the cash flows of the swap contracts, discount rates to account for the passage of time, current foreign exchange and interest rate market data and credit risk, which are all based on inputs readily available in public markets and are categorized as Level 2. The fair value of deferred compensation plans is based on readily available current market data and is categorized as Level 2. The Company’s defined benefit pension plan investments are not required to be measured at fair value on a quarterly recurring basis. There were no changes during the quarter ended March 28, 2020 to the Company’s valuation techniques used to measure asset and liability fair values on a recurring basis. As of and during the quarter ended March 28, 2020 , the Company did not have any non-financial assets or liabilities that were required to be measured at fair value on a recurring or non-recurring basis. The following tables set forth by level within the fair value hierarchy the Company’s financial assets and liabilities accounted for at fair value on a recurring basis. Assets (Liabilities) at Fair Value as of Total Quoted Prices In Significant Significant Forward foreign exchange contracts - assets $ 33,059 $ — $ 33,059 $ — Cross-currency swap contracts - assets 21,741 — 21,741 — Forward foreign exchange contracts - liabilities (3,269 ) — (3,269 ) — 51,531 — 51,531 — Deferred compensation plan liability (17,490 ) — (17,490 ) — Total $ 34,041 $ — $ 34,041 $ — Assets (Liabilities) at Fair Value as of Total Quoted Prices In Significant Significant Forward foreign exchange contracts - assets $ 8,030 $ — $ 8,030 $ — Cross-currency swap contracts - assets 3,901 — 3,901 — Forward foreign exchange contracts - liabilities (3,393 ) — (3,393 ) — 8,538 — 8,538 — Deferred compensation plan liability (31,221 ) — (31,221 ) — Total $ (22,683 ) $ — $ (22,683 ) $ — Fair Value of Financial Instruments The carrying amounts of cash and cash equivalents, trade accounts receivable, notes receivable and accounts payable approximated fair value as of March 28, 2020 and December 28, 2019 . The carrying amount of trade accounts receivable included allowance for doubtful accounts, chargebacks and other deductions of $46,079 and $33,228 as of March 28, 2020 and December 28, 2019 , respectively. The fair value of debt, which is classified as a Level 2 liability, was $4,408,038 and $3,560,623 as of March 28, 2020 and December 28, 2019 , respectively. Debt had a carrying value of $4,526,122 and $3,394,761 as of March 28, 2020 and December 28, 2019 , respectively. The fair values were estimated using quoted market prices as provided in secondary markets, which consider the Company’s credit risk and market related conditions. The carrying amount of the Company’s notes payable, which is classified as a Level 2 liability, approximated fair value as of March 28, 2020 and December 28, 2019 , primarily due to the short-term nature of these instruments.

Income Taxes

Income Taxes	3 Months Ended
	Mar. 28, 2020
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Company’s effective income tax rate was 14.5% and 13.9% for the quarters ended March 28, 2020 and March 30, 2019 , respectively. The effective tax rate was lower for the quarter ended March 30, 2019 due to the inclusion of a net discrete benefit of $ 3,026 . During the quarter ended March 28, 2020 , the Internal Revenue Service closed the examination of the income tax years ended January 2, 2016 and December 31, 2016. The examination resulted in an immaterial adjustment which had been accrued as an uncertain tax benefit in a prior period. The Company remains subject to examinations in other jurisdictions and believes that it maintains appropriate uncertain tax benefit reserves, which are re-evaluated each quarter. Management believes it is reasonably possible that the amount of uncertain tax benefits may decrease by approximately $ 25,318 in the next twelve months based on approvals of certain filings by tax authorities with approximately $ 15,261 of the reduction impacting the effective tax rate. As a result of the COVID-19 pandemic, governments are offering various relief mechanisms to taxpayers to assist with the business disruption. The measures vary by jurisdiction, but often include the ability to delay certain income tax payments. The Company intends to use these provisions where eligible. As of March 28, 2020 , the COVID-19 relief measures do not have a material impact on the effective tax rate or other income tax accounts, including income taxes payable.

Business Segment Information

Business Segment Information	3 Months Ended
	Mar. 28, 2020
Text Block [Abstract]
Business Segment Information	Business Segment Information The Company’s operations are managed and reported in three operating segments, each of which is a reportable segment for financial reporting purposes: Innerwear, Activewear and International. These segments are organized principally by product category and geographic location. Each segment has its own management team that is responsible for the operations of the segment’s businesses, but the segments share a common supply chain and media and marketing platforms. Other consists of the Company’s U.S. value-based (“outlet”) stores and U.S. hosiery business. The types of products and services from which each reportable segment derives its revenues are as follows: • Innerwear includes sales of basic branded apparel products that are replenishment in nature under the product categories of men’s underwear, women’s panties, children’s underwear and socks, and intimate apparel, which includes bras and shapewear. • Activewear includes sales of basic branded products that are primarily seasonal in nature to both retailers and wholesalers, as well as licensed sports apparel and licensed logo apparel in collegiate bookstores, mass retailers and other channels. • International includes sales of products in all of the Company’s categories outside the United States, primarily in Europe, Australia, Asia, Latin America and Canada. The Company evaluates the operating performance of its segments based upon segment operating profit, which is defined as operating profit before general corporate expenses, restructuring and other action-related charges and amortization of intangibles. The accounting policies of the segments are consistent with those described in Note, “Summary of Significant Accounting Policies” to the Company’s consolidated financial statements included in its Annual Report on Form 10-K for the year ended December 28, 2019 . Quarters Ended March 28, March 30, Net sales: Innerwear $ 422,402 $ 475,945 Activewear 288,000 405,340 International 555,901 646,180 Other 50,159 60,559 Total net sales $ 1,316,462 $ 1,588,024 Quarters Ended March 28, March 30, Segment operating profit: Innerwear $ 81,551 $ 104,626 Activewear 8,108 43,593 International 52,018 99,773 Other (6,125 ) 754 Total segment operating profit 135,552 248,746 Items not included in segment operating profit: General corporate expenses (63,633 ) (68,349 ) Restructuring and other action-related charges (29,199 ) (21,373 ) Amortization of intangibles (8,590 ) (9,380 ) Total operating profit 34,130 149,644 Other expenses (6,490 ) (7,451 ) Interest expense, net (36,849 ) (48,059 ) Income (loss) before income tax expense $ (9,209 ) $ 94,134 For the quarter ended March 28, 2020 , the Company incurred pre-tax restructuring and other action-related charges of $29,199 , of which $21,813 is reported in the “Cost of sales” line and $7,386 is reported in the “Selling, general and administrative expenses” line in the Condensed Consolidated Statement of Income. For the quarter ended March 30, 2019 , the Company incurred pre-tax restructuring and other action-related charges of $21,373 , of which $17,692 is reported in the “Cost of sales” line and $3,681 is reported in the “Selling, general and administrative expenses” line in the Condensed Consolidated Statement of Income. As of December 28, 2019 , the Company had an accrual of $7,120 for expected benefit payments related to actions taken in prior years. During the quarter ended March 28, 2020 , the Company approved actions related to corporate workforce reductions and incurred charges of $5,258 for employee termination and other benefits for employees affected by separation programs all of which are reflected in the “Selling, general and administrative expenses” line in the Condensed Consolidated Statement of Income. During quarter ended March 28, 2020 , benefit payments, other accrual adjustments and foreign currency adjustments of $2,616 have been made, resulting in an ending accrual of $9,762 , of which $8,741 and $1,021 is included in the “Accrued liabilities” and “Other noncurrent liabilities” lines of the Condensed Consolidated Balance Sheet, respectively.

Revisions of Previously Issued

Revisions of Previously Issued Condensed Consolidated Financial Statements (Notes)	3 Months Ended
	Mar. 28, 2020
Revisions of Previously Issued Consolidated Financial Statements [Abstract]
Revisions of Previously Issued Consolidated Financial Statements [Text Block]	Revisions of Previously Issued Condensed Consolidated Interim Financial Statements As described in Note, "Basis of Presentation," the following tables set forth the impact of error corrections on the Company’s condensed consolidated interim financial statements as of and for the periods ended March 30, 2019 , June 29, 2019 and September 28, 2019 by financial statement line item. Quarter Ended March 30, 2019 Condensed Consolidated Statement of Income Line Item As Previously Reported Adjustments As Revised Cost of sales $ 967,148 $ 845 $ 967,993 Gross profit 620,876 (845 ) 620,031 Selling, general and administrative expenses 472,838 (2,451 ) 470,387 Operating profit 148,038 1,606 149,644 Income before income tax expense 92,528 1,606 94,134 Net income 79,482 1,606 81,088 Earnings per share: Basic $ 0.22 $ 0.00 $ 0.22 Diluted $ 0.22 $ 0.00 $ 0.22 Quarter Ended March 30, 2019 Condensed Consolidated Statement of Comprehensive Income Line Item As Previously Reported Adjustments As Revised Net income $ 79,482 $ 1,606 $ 81,088 Translation adjustments 14,461 (7,075 ) 7,386 Total other comprehensive income 13,939 (7,075 ) 6,864 Comprehensive income 93,421 (5,469 ) 87,952 March 30, 2019 Condensed Consolidated Balance Sheet Line Item As Previously Reported Adjustments As Revised Inventories $ 2,235,809 $ (3,090 ) $ 2,232,719 Other current assets 166,123 22,889 189,012 Total current assets 3,621,887 19,799 3,641,686 Deferred tax assets 257,393 (43,665 ) 213,728 Total assets 7,848,025 (23,866 ) 7,824,159 Accrued liabilities 552,012 16,438 568,450 Total current liabilities 2,182,435 16,438 2,198,873 Other noncurrent liabilities 286,625 64,743 351,368 Total liabilities 6,809,987 81,181 6,891,168 Retained earnings 1,296,158 (105,047 ) 1,191,111 Total stockholders’ equity 1,038,038 (105,047 ) 932,991 Total liabilities and stockholders’ equity 7,848,025 (23,866 ) 7,824,159 Quarter Ended March 30, 2019 Condensed Consolidated Statement of Stockholders’ Equity Line Item As Previously Reported Adjustments As Revised Balance at December 29, 2018 $ 970,283 $ (98,157 ) $ 872,126 Net income 79,482 1,606 81,088 Other comprehensive income 13,939 (7,075 ) 6,864 Cumulative effect of change in adoption of leases standard 7,977 (1,421 ) 6,556 Balance at March 30, 2019 1,038,038 (105,047 ) 932,991 Quarter Ended March 30, 2019 Condensed Consolidated Statement of Cash Flows Line Item As Previously Reported Adjustments As Revised Operating activities: Net income $ 79,482 $ 1,606 $ 81,088 Adjustments to reconcile net income to net cash from operating activities: Other 11,322 (7,075 ) 4,247 Changes in assets and liabilities: Inventories (183,875 ) 5,470 (178,405 ) Other assets (31,629 ) (743 ) (32,372 ) Accrued liabilities and other (3,120 ) 742 (2,378 ) Net cash from operating activities (194,291 ) — (194,291 ) Quarter Ended June 29, 2019 Condensed Consolidated Statement of Income Line Item As Previously Reported Adjustments As Revised Cost of sales $ 1,086,248 $ (844 ) $ 1,085,404 Gross profit 674,679 844 675,523 Selling, general and administrative expenses 440,662 5,261 445,923 Operating profit 234,017 (4,417 ) 229,600 Income before income tax expense 179,246 (4,417 ) 174,829 Net income 153,972 (4,417 ) 149,555 Earnings per share: Basic $ 0.42 $ (0.01 ) $ 0.41 Diluted $ 0.42 $ (0.01 ) $ 0.41 Six Months Ended June 29, 2019 Condensed Consolidated Statement of Income Line Item As Previously Reported Adjustments As Revised Cost of sales $ 2,053,396 $ 1 $ 2,053,397 Gross profit 1,295,555 (1 ) 1,295,554 Selling, general and administrative expenses 913,500 2,810 916,310 Operating profit 382,055 (2,811 ) 379,244 Income before income tax expense 271,774 (2,811 ) 268,963 Net income 233,454 (2,811 ) 230,643 Earnings per share: Basic $ 0.64 $ (0.01 ) $ 0.63 Diluted $ 0.64 $ (0.01 ) $ 0.63 Quarter Ended June 29, 2019 Condensed Consolidated Statement of Comprehensive Income Line Item As Previously Reported Adjustments As Revised Net income $ 153,972 $ (4,417 ) $ 149,555 Comprehensive income 149,165 (4,417 ) 144,748 Six Months Ended June 29, 2019 Condensed Consolidated Statement of Comprehensive Income Line Item As Previously Reported Adjustments As Revised Net income $ 233,454 $ (2,811 ) $ 230,643 Translation adjustments 11,259 (7,075 ) 4,184 Total other comprehensive income 9,132 (7,075 ) 2,057 Comprehensive income 242,586 (9,886 ) 232,700 June 29, 2019 Condensed Consolidated Balance Sheet Line Item As Previously Reported Adjustments As Revised Inventories $ 2,233,760 $ (10,561 ) $ 2,223,199 Other current assets 152,925 23,371 176,296 Total current assets 3,656,442 12,810 3,669,252 Deferred tax assets 264,592 (43,665 ) 220,927 Total assets 7,876,892 (30,855 ) 7,846,037 Accrued liabilities 547,306 13,866 561,172 Total current liabilities 2,069,817 13,866 2,083,683 Other noncurrent liabilities 277,742 64,743 342,485 Total liabilities 6,742,042 78,609 6,820,651 Retained earnings 1,395,306 (109,464 ) 1,285,842 Total stockholders’ equity 1,134,850 (109,464 ) 1,025,386 Total liabilities and stockholders’ equity 7,876,892 (30,855 ) 7,846,037 Quarter Ended June 29, 2019 Condensed Consolidated Statement of Stockholders’ Equity Line Item As Previously Reported Adjustments As Revised Balance at March 30, 2019 $ 1,038,038 $ (105,047 ) $ 932,991 Net income 153,972 (4,417 ) 149,555 Balance at June 29, 2019 1,134,850 (109,464 ) 1,025,386 Six Months Ended June 29, 2019 Condensed Consolidated Statement of Stockholders’ Equity Line Item As Previously Reported Adjustments As Revised Balance at December 29, 2018 $ 970,283 $ (98,157 ) $ 872,126 Net income 233,454 (2,811 ) 230,643 Other comprehensive income 9,132 (7,075 ) 2,057 Cumulative effect of change in adoption of leases standard 7,977 (1,421 ) 6,556 Balance at June 29, 2019 1,134,850 (109,464 ) 1,025,386 Six Months Ended June 29, 2019 Condensed Consolidated Statement of Cash Flows Line Item As Previously Reported Adjustments As Revised Operating activities: Net income $ 233,454 $ (2,811 ) $ 230,643 Adjustments to reconcile net income to net cash from operating activities: Other 12,550 (7,075 ) 5,475 Changes in assets and liabilities: Inventories (178,453 ) 12,941 (165,512 ) Other assets (27,354 ) (1,225 ) (28,579 ) Accrued liabilities and other (23,405 ) (1,830 ) (25,235 ) Net cash from operating activities (57,363 ) — (57,363 ) Quarter Ended September 28, 2019 Condensed Consolidated Statement of Income Line Item As Previously Reported Adjustments As Revised Cost of sales 1,154,629 (4,695 ) $ 1,149,934 Gross profit 712,338 4,695 717,033 Selling, general and administrative expenses 442,582 7,380 449,962 Operating profit 269,756 (2,685 ) 267,071 Income before income tax expense 218,599 (2,685 ) 215,914 Net income 187,776 (2,685 ) 185,091 Earnings per share: Basic $ 0.51 $ (0.01 ) $ 0.51 Diluted $ 0.51 $ (0.01 ) $ 0.51 Nine Months Ended September 28, 2019 Condensed Consolidated Statement of Income Line Item As Previously Reported Adjustments As Revised Cost of sales $ 3,208,025 $ (4,694 ) $ 3,203,331 Gross profit 2,007,893 4,694 2,012,587 Selling, general and administrative expenses 1,356,082 10,190 1,366,272 Operating profit 651,811 (5,496 ) 646,315 Income before income tax expense 490,373 (5,496 ) 484,877 Net income 421,230 (5,496 ) 415,734 Earnings per share: Basic $ 1.16 $ (0.02 ) $ 1.14 Diluted $ 1.15 $ (0.02 ) $ 1.14 Quarter Ended September 28, 2019 Condensed Consolidated Statement of Comprehensive Income Line Item As Previously Reported Adjustments As Revised Net income $ 187,776 $ (2,685 ) $ 185,091 Comprehensive income 148,443 (2,685 ) 145,758 Nine Months Ended September 28, 2019 Condensed Consolidated Statement of Comprehensive Income Line Item As Previously Reported Adjustments As Revised Net income $ 421,230 $ (5,496 ) $ 415,734 Translation adjustments (33,738 ) (7,075 ) (40,813 ) Total other comprehensive loss (30,201 ) (7,075 ) (37,276 ) Comprehensive income 391,029 (12,571 ) 378,458 September 28, 2019 Condensed Consolidated Balance Sheet Line Item As Previously Reported Adjustments As Revised Inventories $ 2,108,281 $ (13,246 ) $ 2,095,035 Other current assets 166,727 7,445 174,172 Total current assets 3,625,970 (5,801 ) 3,620,169 Deferred tax assets 257,314 (43,665 ) 213,649 Total assets 7,773,298 (49,466 ) 7,723,832 Accrued liabilities 589,992 (2,060 ) 587,932 Total current liabilities 2,096,904 (2,060 ) 2,094,844 Other noncurrent liabilities 265,804 64,743 330,547 Total liabilities 6,543,056 62,683 6,605,739 Retained earnings 1,528,258 (112,149 ) 1,416,109 Total stockholders’ equity 1,230,242 (112,149 ) 1,118,093 Total liabilities and stockholders’ equity 7,773,298 (49,466 ) 7,723,832 Quarter Ended September 28, 2019 Condensed Consolidated Statement of Stockholders’ Equity Line Item As Previously Reported Adjustments As Revised Balance at June 29, 2019 $ 1,134,850 $ (109,464 ) $ 1,025,386 Net income 187,776 (2,685 ) 185,091 Balance at September 28, 2019 1,230,242 (112,149 ) 1,118,093 Nine Months Ended September 28, 2019 Condensed Consolidated Statement of Stockholders’ Equity Line Item As Previously Reported Adjustments As Revised Balance at December 29, 2018 $ 970,283 $ (98,157 ) $ 872,126 Net income 421,230 (5,496 ) 415,734 Other comprehensive income (30,201 ) (7,075 ) (37,276 ) Cumulative effect of change in adoption of leases standard 7,977 (1,421 ) 6,556 Balance at September 28, 2019 1,230,242 (112,149 ) 1,118,093 Nine Months Ended September 28, 2019 Condensed Consolidated Statement of Cash Flows Line Item As Previously Reported Adjustments As Revised Operating activities: Net income $ 421,230 $ (5,496 ) $ 415,734 Adjustments to reconcile net income to net cash from operating activities: Other 8,737 (7,075 ) 1,662 Changes in assets and liabilities, net of acquisition of businesses: Inventories (72,096 ) 15,626 (56,470 ) Other assets (40,732 ) 14,701 (26,031 ) Accrued liabilities and other 14,243 (17,756 ) (3,513 ) Net cash from operating activities 244,700 — 244,700

Revenue Recognition (Policies)

Revenue Recognition (Policies)	3 Months Ended
	Mar. 28, 2020
Revenue from Contract with Customer [Abstract]
Revenue recognition, policy	Revenue is recognized when obligations under the terms of a contract with a customer are satisfied, which occurs at a point in time, upon either shipment or delivery to the customer. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods, which includes estimates for variable consideration. Variable consideration includes trade discounts, rebates, volume-based incentives, cooperative advertising and product returns, which are offered within contracts between the Company and its customers, employing the practical expedient for contract costs. Incidental items that are immaterial to the context of the contract are recognized as expense at the transaction date.

Revenue Recognition (Tables)

Revenue Recognition (Tables)	3 Months Ended
	Mar. 28, 2020
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	The following table presents the Company’s revenues disaggregated by the customer’s method of purchase: Quarters Ended March 28, March 30, Third-party brick-and-mortar wholesale $ 978,127 $ 1,231,423 Consumer-directed 338,335 356,601 Total net sales $ 1,316,462 $ 1,588,024

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	3 Months Ended
	Mar. 28, 2020
Text Block [Abstract]
Reconciliation of Basic to Diluted Weighted Average Shares	The reconciliation of basic to diluted weighted average shares outstanding is as follows: Quarters Ended March 28, March 30, Basic weighted average shares outstanding 359,017 364,570 Effect of potentially dilutive securities: Stock options — 471 Restricted stock units — 254 Employee stock purchase plan and other — 4 Diluted weighted average shares outstanding 359,017 365,299

Inventories (Tables)

Inventories (Tables)	3 Months Ended
	Mar. 28, 2020
Inventory Disclosure [Abstract]
Inventories	Inventories consisted of the following: March 28, December 28, March 30, Raw materials $ 89,558 $ 83,545 $ 118,824 Work in process 124,725 136,592 170,746 Finished goods 1,749,474 1,685,708 1,943,149 $ 1,963,757 $ 1,905,845 $ 2,232,719

Debt (Tables)

Debt (Tables)	3 Months Ended
	Mar. 28, 2020
Debt Disclosure [Abstract]
Debt	Debt and notes payable consisted of the following: Interest Principal Amount Maturity Date March 28, December 28, Senior Secured Credit Facility: Revolving Loan Facility 1.91% $ 950,000 $ — December 2022 Term Loan A 1.89% 625,000 625,000 December 2022 Term Loan B 3.35% 300,000 300,000 December 2024 Australian Revolving Loan Facility 1.67% 30,817 — July 2021 4.875% Senior Notes 4.88% 900,000 900,000 May 2026 4.625% Senior Notes 4.63% 900,000 900,000 May 2024 3.5% Senior Notes 3.50% 556,793 558,847 June 2024 European Revolving Loan Facility 1.50% 111,359 110,914 September 2020 Accounts Receivable Securitization Facility 2.20% 152,153 — March 2021 Total debt 4,526,122 3,394,761 Notes payable 2,170 4,244 Total debt and notes payable 4,528,292 3,399,005 Less long-term debt issuance costs 25,655 26,977 Less notes payable 2,170 4,244 Less current maturities 263,512 110,914 Total long-term debt $ 4,236,955 $ 3,256,870

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Loss (Tables)	3 Months Ended
	Mar. 28, 2020
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Schedule of Accumulated Other Comprehensive Loss	The components of accumulated other comprehensive loss (“AOCI”) are as follows: Cumulative Translation Adjustment (1) Cash Flow Hedges Defined Benefit Plans Income Taxes Accumulated Other Comprehensive Loss Balance at December 28, 2019 $ (157,138 ) $ 4,786 $ (629,360 ) $ 164,064 $ (617,648 ) Amounts reclassified from accumulated other comprehensive loss — (5,017 ) 4,866 — (151 ) Current-period other comprehensive income (loss) activity (117,154 ) 20,080 — (8,552 ) (105,626 ) Balance at March 28, 2020 $ (274,292 ) $ 19,849 $ (624,494 ) $ 155,512 $ (723,425 ) (1) Cumulative Translation Adjustment includes translation adjustments and net investment hedges. See Note, “Financial Instruments and Risk Management” for additional disclosures about net investment hedges.
Schedule of Reclassifications out of Accumulated Other Comprehensive Loss	The Company had the following reclassifications out of AOCI: Component of AOCI Location of Reclassification into Income Amount of Reclassification from AOCI Quarters Ended March 28, March 30, Gain on foreign exchange contracts designated as cash flow hedges Cost of sales $ 5,017 $ 6,017 Income tax (1,272 ) (1,521 ) Net of tax 3,745 4,496 Amortization of deferred actuarial loss and prior service cost Other expenses (4,866 ) (4,602 ) Income tax 1,272 1,205 Net of tax (3,594 ) (3,397 ) Total reclassifications $ 151 $ 1,099

Financial Instruments and Ris_2

Financial Instruments and Risk Management (Tables)	3 Months Ended
	Mar. 28, 2020
Text Block [Abstract]
Fair Values of Derivative Instruments	The fair values of derivative financial instruments related to forward foreign exchange contracts and cross-currency swap contracts recognized in the Condensed Consolidated Balance Sheets of the Company were as follows: Balance Sheet Location Fair Value March 28, December 28, Derivatives designated as hedging instruments: Forward foreign exchange contracts Other current assets $ 17,312 $ 2,716 Cross-currency swap contracts Other current assets 2,873 926 Cross-currency swap contracts Other noncurrent assets 18,868 2,975 Derivatives not designated as hedging instruments: Forward foreign exchange contracts Other current assets 15,747 5,314 Total derivative assets 54,800 11,931 Derivatives designated as hedging instruments: Forward foreign exchange contracts Accrued liabilities (6 ) (2,246 ) Derivatives not designated as hedging instruments: Forward foreign exchange contracts Accrued liabilities (3,263 ) (1,147 ) Total derivative liabilities (3,269 ) (3,393 ) Net derivative asset $ 51,531 $ 8,538
Effect of Cash Flow Hedge Derivative Instruments	The effect of cash flow hedge derivative instruments on the Condensed Consolidated Statements of Income and AOCI is as follows: Amount of Gain Recognized in AOCI on Derivative Instruments Quarters Ended March 28, March 30, Foreign exchange contracts $ 20,080 $ 440 Location of Gain Amount of Gain Reclassified from AOCI into Income Quarters Ended March 28, March 30, Foreign exchange contracts (1) Cost of sales $ 5,017 $ 6,017 (1) The Company does not exclude amounts from effectiveness testing for cash flow hedges that would require recognition into earnings based on changes in fair value. Quarters Ended March 28, March 30, Total cost of sales in which the effects of cash flow hedges are recorded $ 842,730 $ 967,993
Effect of Net Investment Hedge Derivative Instruments	The amount of after-tax gains included in AOCI in the Condensed Consolidated Balance Sheets related to derivative instruments and nonderivative financial instruments designated as net investment hedges and the amount of gains included in the “Interest expense, net” line in the Condensed Consolidated Statements of Income related to amounts excluded from the assessment of hedge effectiveness for derivative instruments designated as net investment hedges are as follows: Amount of Gain Recognized in AOCI Quarters Ended March 28, March 30, Euro-denominated long-term debt $ 2,658 $ — Cross-currency swap contracts 11,732 — Total $ 14,390 $ — Location of Gain Recognized in Income Amount of Gain Recognized in Income Quarters Ended March 28, March 30, Cross-currency swap contracts Interest expense, net $ 1,947 $ — Quarters Ended March 28, March 30, Total interest expense, net in which the amounts excluded from effectiveness testing for net investment hedges are recorded $ 36,849 $ 48,059
Effect of Mark to Market Hedge Derivative Instruments	The effect of derivative contracts not designated as hedges on the Condensed Consolidated Statements of Income is as follows: Location of Gain (Loss) Amount of Gain (Loss) Recognized in Income Quarters Ended March 28, March 30, Foreign exchange contracts Cost of sales $ 6,121 $ (9,397 ) Foreign exchange contracts Selling, general and administrative expenses (1,031 ) (659 ) Total $ 5,090 $ (10,056 )

Fair Value of Assets and Liab_2

Fair Value of Assets and Liabilities (Tables)	3 Months Ended
	Mar. 28, 2020
Text Block [Abstract]
Fair Value of Financial Assets and Liabilities Measured on a Recurring Basis	The following tables set forth by level within the fair value hierarchy the Company’s financial assets and liabilities accounted for at fair value on a recurring basis. Assets (Liabilities) at Fair Value as of Total Quoted Prices In Significant Significant Forward foreign exchange contracts - assets $ 33,059 $ — $ 33,059 $ — Cross-currency swap contracts - assets 21,741 — 21,741 — Forward foreign exchange contracts - liabilities (3,269 ) — (3,269 ) — 51,531 — 51,531 — Deferred compensation plan liability (17,490 ) — (17,490 ) — Total $ 34,041 $ — $ 34,041 $ — Assets (Liabilities) at Fair Value as of Total Quoted Prices In Significant Significant Forward foreign exchange contracts - assets $ 8,030 $ — $ 8,030 $ — Cross-currency swap contracts - assets 3,901 — 3,901 — Forward foreign exchange contracts - liabilities (3,393 ) — (3,393 ) — 8,538 — 8,538 — Deferred compensation plan liability (31,221 ) — (31,221 ) — Total $ (22,683 ) $ — $ (22,683 ) $ —

Business Segment Information (T

Business Segment Information (Tables)	3 Months Ended
	Mar. 28, 2020
Text Block [Abstract]
Net Sales	Quarters Ended March 28, March 30, Net sales: Innerwear $ 422,402 $ 475,945 Activewear 288,000 405,340 International 555,901 646,180 Other 50,159 60,559 Total net sales $ 1,316,462 $ 1,588,024
Segment Operating Profit	Quarters Ended March 28, March 30, Segment operating profit: Innerwear $ 81,551 $ 104,626 Activewear 8,108 43,593 International 52,018 99,773 Other (6,125 ) 754 Total segment operating profit 135,552 248,746 Items not included in segment operating profit: General corporate expenses (63,633 ) (68,349 ) Restructuring and other action-related charges (29,199 ) (21,373 ) Amortization of intangibles (8,590 ) (9,380 ) Total operating profit 34,130 149,644 Other expenses (6,490 ) (7,451 ) Interest expense, net (36,849 ) (48,059 ) Income (loss) before income tax expense $ (9,209 ) $ 94,134

Revisions of Previously Issue_2

Revisions of Previously Issued Condensed Consolidated Financial Statements (Tables)	3 Months Ended
	Mar. 28, 2020
Revisions of Previously Issued Consolidated Financial Statements [Abstract]
Revisions of Previously Issued Consolidated Financial Statements [Table Text Block]	As described in Note, "Basis of Presentation," the following tables set forth the impact of error corrections on the Company’s condensed consolidated interim financial statements as of and for the periods ended March 30, 2019 , June 29, 2019 and September 28, 2019 by financial statement line item. Quarter Ended March 30, 2019 Condensed Consolidated Statement of Income Line Item As Previously Reported Adjustments As Revised Cost of sales $ 967,148 $ 845 $ 967,993 Gross profit 620,876 (845 ) 620,031 Selling, general and administrative expenses 472,838 (2,451 ) 470,387 Operating profit 148,038 1,606 149,644 Income before income tax expense 92,528 1,606 94,134 Net income 79,482 1,606 81,088 Earnings per share: Basic $ 0.22 $ 0.00 $ 0.22 Diluted $ 0.22 $ 0.00 $ 0.22 Quarter Ended March 30, 2019 Condensed Consolidated Statement of Comprehensive Income Line Item As Previously Reported Adjustments As Revised Net income $ 79,482 $ 1,606 $ 81,088 Translation adjustments 14,461 (7,075 ) 7,386 Total other comprehensive income 13,939 (7,075 ) 6,864 Comprehensive income 93,421 (5,469 ) 87,952 March 30, 2019 Condensed Consolidated Balance Sheet Line Item As Previously Reported Adjustments As Revised Inventories $ 2,235,809 $ (3,090 ) $ 2,232,719 Other current assets 166,123 22,889 189,012 Total current assets 3,621,887 19,799 3,641,686 Deferred tax assets 257,393 (43,665 ) 213,728 Total assets 7,848,025 (23,866 ) 7,824,159 Accrued liabilities 552,012 16,438 568,450 Total current liabilities 2,182,435 16,438 2,198,873 Other noncurrent liabilities 286,625 64,743 351,368 Total liabilities 6,809,987 81,181 6,891,168 Retained earnings 1,296,158 (105,047 ) 1,191,111 Total stockholders’ equity 1,038,038 (105,047 ) 932,991 Total liabilities and stockholders’ equity 7,848,025 (23,866 ) 7,824,159 Quarter Ended March 30, 2019 Condensed Consolidated Statement of Stockholders’ Equity Line Item As Previously Reported Adjustments As Revised Balance at December 29, 2018 $ 970,283 $ (98,157 ) $ 872,126 Net income 79,482 1,606 81,088 Other comprehensive income 13,939 (7,075 ) 6,864 Cumulative effect of change in adoption of leases standard 7,977 (1,421 ) 6,556 Balance at March 30, 2019 1,038,038 (105,047 ) 932,991 Quarter Ended March 30, 2019 Condensed Consolidated Statement of Cash Flows Line Item As Previously Reported Adjustments As Revised Operating activities: Net income $ 79,482 $ 1,606 $ 81,088 Adjustments to reconcile net income to net cash from operating activities: Other 11,322 (7,075 ) 4,247 Changes in assets and liabilities: Inventories (183,875 ) 5,470 (178,405 ) Other assets (31,629 ) (743 ) (32,372 ) Accrued liabilities and other (3,120 ) 742 (2,378 ) Net cash from operating activities (194,291 ) — (194,291 ) Quarter Ended June 29, 2019 Condensed Consolidated Statement of Income Line Item As Previously Reported Adjustments As Revised Cost of sales $ 1,086,248 $ (844 ) $ 1,085,404 Gross profit 674,679 844 675,523 Selling, general and administrative expenses 440,662 5,261 445,923 Operating profit 234,017 (4,417 ) 229,600 Income before income tax expense 179,246 (4,417 ) 174,829 Net income 153,972 (4,417 ) 149,555 Earnings per share: Basic $ 0.42 $ (0.01 ) $ 0.41 Diluted $ 0.42 $ (0.01 ) $ 0.41 Six Months Ended June 29, 2019 Condensed Consolidated Statement of Income Line Item As Previously Reported Adjustments As Revised Cost of sales $ 2,053,396 $ 1 $ 2,053,397 Gross profit 1,295,555 (1 ) 1,295,554 Selling, general and administrative expenses 913,500 2,810 916,310 Operating profit 382,055 (2,811 ) 379,244 Income before income tax expense 271,774 (2,811 ) 268,963 Net income 233,454 (2,811 ) 230,643 Earnings per share: Basic $ 0.64 $ (0.01 ) $ 0.63 Diluted $ 0.64 $ (0.01 ) $ 0.63 Quarter Ended June 29, 2019 Condensed Consolidated Statement of Comprehensive Income Line Item As Previously Reported Adjustments As Revised Net income $ 153,972 $ (4,417 ) $ 149,555 Comprehensive income 149,165 (4,417 ) 144,748 Six Months Ended June 29, 2019 Condensed Consolidated Statement of Comprehensive Income Line Item As Previously Reported Adjustments As Revised Net income $ 233,454 $ (2,811 ) $ 230,643 Translation adjustments 11,259 (7,075 ) 4,184 Total other comprehensive income 9,132 (7,075 ) 2,057 Comprehensive income 242,586 (9,886 ) 232,700 June 29, 2019 Condensed Consolidated Balance Sheet Line Item As Previously Reported Adjustments As Revised Inventories $ 2,233,760 $ (10,561 ) $ 2,223,199 Other current assets 152,925 23,371 176,296 Total current assets 3,656,442 12,810 3,669,252 Deferred tax assets 264,592 (43,665 ) 220,927 Total assets 7,876,892 (30,855 ) 7,846,037 Accrued liabilities 547,306 13,866 561,172 Total current liabilities 2,069,817 13,866 2,083,683 Other noncurrent liabilities 277,742 64,743 342,485 Total liabilities 6,742,042 78,609 6,820,651 Retained earnings 1,395,306 (109,464 ) 1,285,842 Total stockholders’ equity 1,134,850 (109,464 ) 1,025,386 Total liabilities and stockholders’ equity 7,876,892 (30,855 ) 7,846,037 Quarter Ended June 29, 2019 Condensed Consolidated Statement of Stockholders’ Equity Line Item As Previously Reported Adjustments As Revised Balance at March 30, 2019 $ 1,038,038 $ (105,047 ) $ 932,991 Net income 153,972 (4,417 ) 149,555 Balance at June 29, 2019 1,134,850 (109,464 ) 1,025,386 Six Months Ended June 29, 2019 Condensed Consolidated Statement of Stockholders’ Equity Line Item As Previously Reported Adjustments As Revised Balance at December 29, 2018 $ 970,283 $ (98,157 ) $ 872,126 Net income 233,454 (2,811 ) 230,643 Other comprehensive income 9,132 (7,075 ) 2,057 Cumulative effect of change in adoption of leases standard 7,977 (1,421 ) 6,556 Balance at June 29, 2019 1,134,850 (109,464 ) 1,025,386 Six Months Ended June 29, 2019 Condensed Consolidated Statement of Cash Flows Line Item As Previously Reported Adjustments As Revised Operating activities: Net income $ 233,454 $ (2,811 ) $ 230,643 Adjustments to reconcile net income to net cash from operating activities: Other 12,550 (7,075 ) 5,475 Changes in assets and liabilities: Inventories (178,453 ) 12,941 (165,512 ) Other assets (27,354 ) (1,225 ) (28,579 ) Accrued liabilities and other (23,405 ) (1,830 ) (25,235 ) Net cash from operating activities (57,363 ) — (57,363 ) Quarter Ended September 28, 2019 Condensed Consolidated Statement of Income Line Item As Previously Reported Adjustments As Revised Cost of sales 1,154,629 (4,695 ) $ 1,149,934 Gross profit 712,338 4,695 717,033 Selling, general and administrative expenses 442,582 7,380 449,962 Operating profit 269,756 (2,685 ) 267,071 Income before income tax expense 218,599 (2,685 ) 215,914 Net income 187,776 (2,685 ) 185,091 Earnings per share: Basic $ 0.51 $ (0.01 ) $ 0.51 Diluted $ 0.51 $ (0.01 ) $ 0.51 Nine Months Ended September 28, 2019 Condensed Consolidated Statement of Income Line Item As Previously Reported Adjustments As Revised Cost of sales $ 3,208,025 $ (4,694 ) $ 3,203,331 Gross profit 2,007,893 4,694 2,012,587 Selling, general and administrative expenses 1,356,082 10,190 1,366,272 Operating profit 651,811 (5,496 ) 646,315 Income before income tax expense 490,373 (5,496 ) 484,877 Net income 421,230 (5,496 ) 415,734 Earnings per share: Basic $ 1.16 $ (0.02 ) $ 1.14 Diluted $ 1.15 $ (0.02 ) $ 1.14 Quarter Ended September 28, 2019 Condensed Consolidated Statement of Comprehensive Income Line Item As Previously Reported Adjustments As Revised Net income $ 187,776 $ (2,685 ) $ 185,091 Comprehensive income 148,443 (2,685 ) 145,758 Nine Months Ended September 28, 2019 Condensed Consolidated Statement of Comprehensive Income Line Item As Previously Reported Adjustments As Revised Net income $ 421,230 $ (5,496 ) $ 415,734 Translation adjustments (33,738 ) (7,075 ) (40,813 ) Total other comprehensive loss (30,201 ) (7,075 ) (37,276 ) Comprehensive income 391,029 (12,571 ) 378,458 September 28, 2019 Condensed Consolidated Balance Sheet Line Item As Previously Reported Adjustments As Revised Inventories $ 2,108,281 $ (13,246 ) $ 2,095,035 Other current assets 166,727 7,445 174,172 Total current assets 3,625,970 (5,801 ) 3,620,169 Deferred tax assets 257,314 (43,665 ) 213,649 Total assets 7,773,298 (49,466 ) 7,723,832 Accrued liabilities 589,992 (2,060 ) 587,932 Total current liabilities 2,096,904 (2,060 ) 2,094,844 Other noncurrent liabilities 265,804 64,743 330,547 Total liabilities 6,543,056 62,683 6,605,739 Retained earnings 1,528,258 (112,149 ) 1,416,109 Total stockholders’ equity 1,230,242 (112,149 ) 1,118,093 Total liabilities and stockholders’ equity 7,773,298 (49,466 ) 7,723,832 Quarter Ended September 28, 2019 Condensed Consolidated Statement of Stockholders’ Equity Line Item As Previously Reported Adjustments As Revised Balance at June 29, 2019 $ 1,134,850 $ (109,464 ) $ 1,025,386 Net income 187,776 (2,685 ) 185,091 Balance at September 28, 2019 1,230,242 (112,149 ) 1,118,093 Nine Months Ended September 28, 2019 Condensed Consolidated Statement of Stockholders’ Equity Line Item As Previously Reported Adjustments As Revised Balance at December 29, 2018 $ 970,283 $ (98,157 ) $ 872,126 Net income 421,230 (5,496 ) 415,734 Other comprehensive income (30,201 ) (7,075 ) (37,276 ) Cumulative effect of change in adoption of leases standard 7,977 (1,421 ) 6,556 Balance at September 28, 2019 1,230,242 (112,149 ) 1,118,093 Nine Months Ended September 28, 2019 Condensed Consolidated Statement of Cash Flows Line Item As Previously Reported Adjustments As Revised Operating activities: Net income $ 421,230 $ (5,496 ) $ 415,734 Adjustments to reconcile net income to net cash from operating activities: Other 8,737 (7,075 ) 1,662 Changes in assets and liabilities, net of acquisition of businesses: Inventories (72,096 ) 15,626 (56,470 ) Other assets (40,732 ) 14,701 (26,031 ) Accrued liabilities and other 14,243 (17,756 ) (3,513 ) Net cash from operating activities 244,700 — 244,700

Basis of Presentation Additiona

Basis of Presentation Additional Information (Details) - Revolving Loan Facility - USD ($) $ in Thousands	Apr. 28, 2020	Mar. 28, 2020
Debt Instrument [Line Items]
Revolving Loan Facility Draw Down		$ 630,000
Subsequent Event [Member]
Debt Instrument [Line Items]
Revolving Loan Facility Repayment	$ 490,000

Revenue Recognition (Details)

Revenue Recognition (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 28, 2020	Mar. 30, 2019
Disaggregation of Revenue
Net sales	$ 1,316,462	$ 1,588,024
Third-party brick-and-mortar wholesale
Disaggregation of Revenue
Net sales	978,127	1,231,423
Consumer-directed
Disaggregation of Revenue
Net sales	$ 338,335	$ 356,601

Acquisitions Narrative (Details

Acquisitions Narrative (Details) - Bras N Things $ in Thousands, $ in Thousands	Feb. 12, 2018AUD ($)	Feb. 12, 2018USD ($)	Sep. 28, 2019AUD ($)	Sep. 28, 2019USD ($)	Mar. 30, 2019USD ($)	Dec. 29, 2018AUD ($)	Dec. 29, 2018USD ($)	Feb. 12, 2018USD ($)
Business Acquisition [Line Items]
Business acquistion, percent of business acquired	100.00%							100.00%
Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred	$ 498,236	$ 391,572
Increase (decrease) in consideration transferred						$ (3,012)	$ (2,367)
Total purchase price	495,224	389,205
Cash consideration paid	428,956	$ 337,123
Indemnification escrow asset	31,988							$ 25,140
Debt assumed	$ 34,280							$ 26,942
Indemnification escrow disbursement			$ 31,425	$ 21,360
Goodwill, Purchase Accounting Adjustments					$ (792)

Stockholders' Equity Reconcilia

Stockholders' Equity Reconciliation of Basic to Diluted Weighted Average Shares (Detail) - shares shares in Thousands	3 Months Ended
	Mar. 28, 2020	Mar. 30, 2019
Reconciliation of basic to diluted weighted average shares [Line Items]
Basic weighted average shares outstanding	359,017	364,570
Diluted weighted average shares outstanding	359,017	365,299
Stock options
Effect of potentially dilutive securities:
Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements	0	471
Restricted stock units
Effect of potentially dilutive securities:
Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements	0	254
Employee stock purchase plan and other
Effect of potentially dilutive securities:
Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements	0	4

Stockholders' Equity (Narrative

Stockholders' Equity (Narrative) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 28, 2020	Mar. 30, 2019	Feb. 06, 2020	Apr. 27, 2016
Stockholders' Equity [Line Items]
Dividends, Per Share, Declared	$ 0.15	$ 0.15
Stock Repurchased During Period, Value	$ 200,269
Stock options
Stockholders' Equity [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount		0
Restricted stock units
Stockholders' Equity [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount		5
2020 Share Repurchase Plan
Stockholders' Equity [Line Items]
Stock Repurchase Program, Number of Shares Authorized to be Repurchased			40,000
Stock Repurchased During Period, Shares	14,464
Common Stock Repurchased - Weighted Average Price Per Share	$ 13.83
Stock Repurchased During Period, Value	$ 200,269
Remaining number of shares authorized to be repurchased	25,536
2016 Share Repurchase Plan
Stockholders' Equity [Line Items]
Stock Repurchase Program, Number of Shares Authorized to be Repurchased				40,000

Inventories (Detail)

Inventories (Detail) - USD ($) $ in Thousands	Mar. 28, 2020	Dec. 28, 2019	Mar. 30, 2019
Inventory Disclosure [Abstract]
Raw materials	$ 89,558	$ 83,545	$ 118,824
Work in process	124,725	136,592	170,746
Finished goods	1,749,474	1,685,708	1,943,149
Total Inventories	$ 1,963,757	$ 1,905,845	$ 2,232,719

Debt (Detail)

Debt (Detail) - USD ($) $ in Thousands	Mar. 28, 2020	Dec. 28, 2019	Mar. 30, 2019
Debt Instrument [Line Items]
Total debt	$ 4,526,122	$ 3,394,761
Notes payable	2,170	4,244
Total debt and notes payable	4,528,292	3,399,005
Long-term Debt, Excluding Current Maturities [Abstract]
Less long-term debt issuance costs	25,655	26,977
Notes payable	2,170	4,244
Less current maturities	263,512	110,914
Total long-term debt	$ 4,236,955	3,256,870	$ 3,615,493
Revolving Loan Facility
Debt Instrument [Line Items]
Interest rate as of March 28, 2020	1.91%
Total debt	$ 950,000	0
Term Loan A
Debt Instrument [Line Items]
Interest rate as of March 28, 2020	1.89%
Total debt	$ 625,000	625,000
Term Loan B
Debt Instrument [Line Items]
Interest rate as of March 28, 2020	3.35%
Total debt	$ 300,000	300,000
Australian Revolving Loan Facility
Debt Instrument [Line Items]
Interest rate as of March 28, 2020	1.67%
Total debt	$ 30,817	0
4.875% Senior Notes
Debt Instrument [Line Items]
Interest rate as of March 28, 2020	4.88%
Total debt	$ 900,000	900,000
4.625% Senior Notes
Debt Instrument [Line Items]
Interest rate as of March 28, 2020	4.63%
Total debt	$ 900,000	900,000
3.50% Senior Notes
Debt Instrument [Line Items]
Total debt	$ 556,793	558,847
European Revolving Loan Facility
Debt Instrument [Line Items]
Interest rate as of March 28, 2020	1.50%
Total debt	$ 111,359	110,914
Accounts Receivable Securitization Facility
Debt Instrument [Line Items]
Interest rate as of March 28, 2020	2.20%
Total debt	$ 152,153	$ 0

Debt (Additional Information) (

Debt (Additional Information) (Detail) $ in Thousands	Apr. 28, 2020USD ($)	Jul. 03, 2021USD ($)	Apr. 03, 2021USD ($)	Jan. 02, 2021USD ($)	Sep. 26, 2020USD ($)	Jun. 27, 2020USD ($)	Mar. 28, 2020USD ($)	Dec. 28, 2019USD ($)
Revolving Loan Facility
Debt Instrument [Line Items]
Remaining capacity							$ 45,924
Maximum borrowing capacity							1,000,000
Standby and trade letters of credit issued							4,076
Revolving Loan Facility Draw Down							630,000
Accounts Receivable Securitization Facility
Debt Instrument [Line Items]
Remaining capacity							0
Maximum borrowing capacity							225,000	$ 300,000
Line of Credit Facility, Current Borrowing Capacity							175,000
Australian Revolving Loan Facility
Debt Instrument [Line Items]
Remaining capacity							5,958
European Revolving Loan Facility
Debt Instrument [Line Items]
Remaining capacity							0
Other International Debt
Debt Instrument [Line Items]
Remaining capacity							$ 134,716
Senior Secured Credit Facility [Member]
Debt Instrument [Line Items]
Interest Coverage Ratio							3
Minimum | Senior Secured Credit Facility [Member]
Debt Instrument [Line Items]
Minimum Liquidity Covenant							$ 300,000
Maximum | Senior Secured Credit Facility [Member]
Debt Instrument [Line Items]
Minimum Liquidity Covenant							$ 400,000
Subsequent Event [Member] | Revolving Loan Facility
Debt Instrument [Line Items]
Revolving Loan Facility Repayment	$ 490,000
Subsequent Event [Member] | Senior Secured Credit Facility [Member]
Debt Instrument [Line Items]
Interest Coverage Ratio		2.25	2	2	2	2
Minimum Last Twelve Months EBITDA Covenant		$ 505,000	$ 435,000	$ 445,000	$ 505,000	$ 625,000

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Loss (Rollforward) (Details) $ in Thousands	3 Months Ended
	Mar. 28, 2020USD ($)
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Balance at December 28, 2019, net of tax	$ (617,648)
Balance at March 28, 2020, net of tax	(723,425)
Cumulative Translation Adjustment
Accumulated Other Comprehensive Income (Loss), Before Tax [Roll Forward]
Balance at December 28, 2019, before tax	(157,138)
Amounts reclassified from accumulated other comprehensive loss, before tax	0
Current-period other comprehensive income (loss) activity, before tax	(117,154)
Balance at March 28, 2020, before tax	(274,292)
Cash Flow Hedges
Accumulated Other Comprehensive Income (Loss), Before Tax [Roll Forward]
Balance at December 28, 2019, before tax	4,786
Amounts reclassified from accumulated other comprehensive loss, before tax	(5,017)
Current-period other comprehensive income (loss) activity, before tax	20,080
Balance at March 28, 2020, before tax	19,849
Defined Benefit Plans
Accumulated Other Comprehensive Income (Loss), Before Tax [Roll Forward]
Balance at December 28, 2019, before tax	(629,360)
Amounts reclassified from accumulated other comprehensive loss, before tax	4,866
Current-period other comprehensive income (loss) activity, before tax	0
Balance at March 28, 2020, before tax	(624,494)
Income Taxes
Accumulated Other Comprehensive Income (Loss), Tax [Roll Forward]
Balance at December 28, 2019, tax	164,064
Amounts reclassified from accumulated other comprehensive loss, tax	0
Current-period other comprehensive income (loss) activity, tax	(8,552)
Balance at March 28, 2020, tax	155,512
Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Balance at December 28, 2019, net of tax	(617,648)
Amounts reclassified from accumulated other comprehensive loss, net of tax	(151)
Current-period other comprehensive income (loss) activity, net of tax	(105,626)
Balance at March 28, 2020, net of tax	$ (723,425)

Accumulated Other Comprehensi_4

Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 28, 2020	Mar. 30, 2019
Reclassification out of Accumulated Other Comprehensive Income [Line Items]
Cost of sales	$ 842,730	$ 967,993
Other expenses	(6,490)	(7,451)
Income tax expense (benefit)	1,335	(13,046)
Net income (loss)	(7,874)	81,088
Reclassification out of Accumulated Other Comprehensive Income
Reclassification out of Accumulated Other Comprehensive Income [Line Items]
Net income (loss)	151	1,099
Reclassification out of Accumulated Other Comprehensive Income | Amortization of deferred actuarial loss and prior service cost
Reclassification out of Accumulated Other Comprehensive Income [Line Items]
Other expenses	(4,866)	(4,602)
Income tax expense (benefit)	1,272	1,205
Net income (loss)	(3,594)	(3,397)
Foreign Exchange Contract | Reclassification out of Accumulated Other Comprehensive Income | Gain on foreign exchange contracts designated as cash flow hedges
Reclassification out of Accumulated Other Comprehensive Income [Line Items]
Cost of sales	5,017	6,017
Income tax expense (benefit)	(1,272)	(1,521)
Net income (loss)	$ 3,745	$ 4,496

Financial Instruments and Ris_3

Financial Instruments and Risk Management (Additional Information) (Detail) € in Thousands, $ in Thousands	3 Months Ended
	Mar. 28, 2020USD ($)	Jul. 10, 2019EUR (€)
Foreign Exchange Contract
Derivative [Line Items]
Derivative, Notional Amount	$ 553,575
Amount expected to be reclassified into earnings during the next twelve months	$ 21,396
Maximum Length of Time Hedged in Interest Rate Cash Flow Hedge	14 months
Cross-Currency Swap Contract
Derivative [Line Items]
Number of cross currency swaps		2
Derivative, Notional Amount	$ 335,940	€ 300,000

Financial Instruments and Ris_4

Financial Instruments and Risk Management Fair Values of Derivative Instruments (Detail) - USD ($) $ in Thousands	Mar. 28, 2020	Dec. 28, 2019
Derivatives, Fair Value [Line Items]
Net fair value of derivative assets and liabilities	$ 51,531	$ 8,538
Assets, Total
Derivatives, Fair Value [Line Items]
Total derivative assets	54,800	11,931
Liabilities, Total
Derivatives, Fair Value [Line Items]
Total derivative liabilities	3,269	3,393
Foreign Exchange Contract | Other current assets | Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Total derivative assets	17,312	2,716
Foreign Exchange Contract | Other current assets | Non-hedges
Derivatives, Fair Value [Line Items]
Total derivative assets	15,747	5,314
Foreign Exchange Contract | Accrued liabilities | Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Total derivative liabilities	6	2,246
Foreign Exchange Contract | Accrued liabilities | Non-hedges
Derivatives, Fair Value [Line Items]
Total derivative liabilities	3,263	1,147
Cross-Currency Swap Contract | Other current assets | Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Total derivative assets	2,873	926
Cross-Currency Swap Contract | Other noncurrent assets | Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Total derivative assets	$ 18,868	$ 2,975

Financial Instruments and Ris_5

Financial Instruments and Risk Management Effect of Cash Flow Hedge Derivative Instruments (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 28, 2020	Mar. 30, 2019
Derivatives, Fair Value [Line Items]
Cost of sales	$ 842,730	$ 967,993
Foreign Exchange Contract
Derivatives, Fair Value [Line Items]
Amount of Gain Recognized in AOCI	20,080	440
Foreign Exchange Contract | Cost of Sales
Derivatives, Fair Value [Line Items]
Amount of Gain Reclassified from AOCI into Income	$ 5,017	$ 6,017

Financial Instruments and Ris_6

Financial Instruments and Risk Management Effect of Net Investment Hedge Instruments (Detail) € in Thousands, $ in Thousands	Jul. 10, 2019EUR (€)	Mar. 28, 2020USD ($)	Mar. 30, 2019USD ($)
Derivatives, Fair Value [Line Items]
Interest expense, net		$ 36,849	$ 48,059
4.625% Senior Notes
Derivatives, Fair Value [Line Items]
Interest Rate on Senior Notes Issued		4.63%
Euro-denominated Long-term Debt | 3.50% Senior Notes
Derivatives, Fair Value [Line Items]
Interest Rate on Senior Notes Issued		3.50%
Notional Amount of Nonderivative Instruments	€ 500,000	$ 556,793
Cross-Currency Swap Contract
Derivatives, Fair Value [Line Items]
Cross-Currency Swap Contract - Fixed Interest Rate	2.3215%
Cross-Currency Swap Contract | Interest expense, net
Derivatives, Fair Value [Line Items]
Amounts of Gain (Loss) Recognized in Income		$ 1,947	0
Cross-Currency Swap Contract | 4.625% Senior Notes
Derivatives, Fair Value [Line Items]
Interest Rate on Senior Notes Issued		4.625%
Accumulated Other Comprehensive Loss
Derivatives, Fair Value [Line Items]
Amount of Gain (Loss) Recognized in AOCI on Net Investment Hedges		$ 14,390	0
Accumulated Other Comprehensive Loss | Euro-denominated Long-term Debt
Derivatives, Fair Value [Line Items]
Amount of Gain (Loss) Recognized in AOCI		2,658	0
Accumulated Other Comprehensive Loss | Cross-Currency Swap Contract
Derivatives, Fair Value [Line Items]
Amount of Gain (Loss) Recognized in AOCI		$ 11,732	$ 0

Financial Instruments and Ris_7

Financial Instruments and Risk Management Effect of Mark to Market Hedge Derivative Instruments (Detail) - Foreign Exchange Contract - USD ($) $ in Thousands	3 Months Ended
	Mar. 28, 2020	Mar. 30, 2019
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Recognized in Income	$ 5,090	$ (10,056)
Cost of Sales
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Recognized in Income	6,121	(9,397)
Selling, general and administrative expenses
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Recognized in Income	$ (1,031)	$ (659)

Fair Value of Assets and Liab_3

Fair Value of Assets and Liabilities (Additional Information) (Detail) - USD ($) $ in Thousands	Mar. 28, 2020	Dec. 28, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Accounts Receivable, Allowance for Credit Loss, Current	$ 46,079	$ 33,228
Carrying value of debt	4,526,122	3,394,761
Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of debt	$ 4,408,038	$ 3,560,623

Fair Value of Assets and Liab_4

Fair Value of Assets and Liabilities (Fair Value of Financial Assets and Liabilities Measured on Recurring Basis) (Detail) - USD ($) $ in Thousands	Mar. 28, 2020	Dec. 28, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Net fair value of derivative assets and liabilities	$ 51,531	$ 8,538
Fair Value, Measurements, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Net fair value of derivative assets and liabilities	51,531	8,538
Deferred compensation plan liability	17,490	31,221
Net Effect Of Financial Asset Less Financial Liability	34,041	(22,683)
Fair Value, Measurements, Recurring | Quoted Prices In Active Markets for Identical Assets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Net fair value of derivative assets and liabilities	0	0
Deferred compensation plan liability	0	0
Net Effect Of Financial Asset Less Financial Liability	0	0
Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Net fair value of derivative assets and liabilities	51,531	8,538
Deferred compensation plan liability	17,490	31,221
Net Effect Of Financial Asset Less Financial Liability	34,041	(22,683)
Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Net fair value of derivative assets and liabilities	0	0
Deferred compensation plan liability	0	0
Net Effect Of Financial Asset Less Financial Liability	0	0
Fair Value, Measurements, Recurring | Foreign exchange derivative contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total derivative assets	33,059	8,030
Total derivative liabilities	3,269	3,393
Fair Value, Measurements, Recurring | Foreign exchange derivative contracts | Quoted Prices In Active Markets for Identical Assets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total derivative assets	0	0
Total derivative liabilities	0	0
Fair Value, Measurements, Recurring | Foreign exchange derivative contracts | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total derivative assets	33,059	8,030
Total derivative liabilities	3,269	3,393
Fair Value, Measurements, Recurring | Foreign exchange derivative contracts | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total derivative assets	0	0
Total derivative liabilities	0	0
Fair Value, Measurements, Recurring | Cross-Currency Swap Contract
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total derivative assets	21,741	3,901
Fair Value, Measurements, Recurring | Cross-Currency Swap Contract | Quoted Prices In Active Markets for Identical Assets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total derivative assets	0	0
Fair Value, Measurements, Recurring | Cross-Currency Swap Contract | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total derivative assets	21,741	3,901
Fair Value, Measurements, Recurring | Cross-Currency Swap Contract | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total derivative assets	$ 0	$ 0

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 28, 2020	Mar. 30, 2019
Income Tax Benefit	$ (1,335)	$ 13,046
Effective Income Tax Rate, Percent	14.50%	13.90%
Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit	$ 25,318
Unrecognized Tax Benefits that Would Impact Effective Tax Rate	$ 15,261
Discrete benefit [Member]
Income Tax Benefit		$ 3,026

Business Segment Information (D

Business Segment Information (Detail) $ in Thousands	3 Months Ended
	Mar. 28, 2020USD ($)	Mar. 30, 2019USD ($)	Dec. 28, 2019USD ($)
Segment Reporting Information [Line Items]
Number of operating segments	3
Net sales:
Net sales	$ 1,316,462	$ 1,588,024
Segment operating profit:
Total operating profit	34,130	149,644
General corporate expenses	63,633	68,349
Restructuring and other action-related charges	29,199	21,373
Amortization of intangibles	8,590	9,380
Other expenses	(6,490)	(7,451)
Interest expense, net	(36,849)	(48,059)
Income (loss) before income tax expense	(9,209)	94,134
Other Employee Related Liabilities	9,762		$ 7,120
Employee termination and other benefits	5,258
Employee termination and other benefits paid	(2,616)
Innerwear
Net sales:
Net sales	422,402	475,945
Segment operating profit:
Total operating profit	81,551	104,626
Activewear
Net sales:
Net sales	288,000	405,340
Segment operating profit:
Total operating profit	8,108	43,593
International
Net sales:
Net sales	555,901	646,180
Segment operating profit:
Total operating profit	52,018	99,773
Total segment operating profit
Segment operating profit:
Total operating profit	135,552	248,746
Accrued liabilities
Segment operating profit:
Other Employee Related Liabilities	8,741
Other Noncurrent Liabilities
Segment operating profit:
Other Employee Related Liabilities	1,021
Total
Segment operating profit:
Restructuring and other action-related charges	29,199	21,373
Cost of Sales
Segment operating profit:
Restructuring and other action-related charges	21,813	17,692
Selling, general and administrative expenses
Segment operating profit:
Restructuring and other action-related charges	7,386	3,681
Corporate, Non-Segment
Net sales:
Net sales	50,159	60,559
Segment operating profit:
Total operating profit	$ (6,125)	$ 754

Revisions of Previously Issue_3

Revisions of Previously Issued Condensed Consolidated Financial Statements (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended				6 Months Ended	9 Months Ended
	Mar. 28, 2020	Sep. 28, 2019	Jun. 29, 2019	Mar. 30, 2019	Jun. 29, 2019	Sep. 28, 2019	Mar. 28, 2020	Dec. 28, 2019	Sep. 28, 2019	Jun. 29, 2019	Mar. 30, 2019
Income Statement [Abstract]
Cost of sales	$ 842,730			$ 967,993
Gross profit	473,732			620,031
Selling, general and administrative expenses	439,602			470,387
Operating profit	34,130			149,644
Income before income tax expense	(9,209)			94,134
Net income (loss)	(7,874)			81,088
Other Comprehensive income (loss):
Net income (loss)	(7,874)			81,088
Translation adjustments	(117,154)			7,386
Other comprehensive income (loss)	(105,777)			6,864
Comprehensive income	(113,651)			87,952
Assets
Inventories							$ 1,963,757	$ 1,905,845			$ 2,232,719
Other current assets							178,244	174,634			189,012
Total current assets							3,950,873	3,224,565			3,641,686
Deferred tax assets							188,004	203,331			213,728
Total assets							7,943,259	7,353,986			7,824,159
Liabilities and Stockholders' Equity
Accrued liabilities							447,401	531,184			568,450
Total current liabilities							1,789,068	1,771,439			2,198,873
Other noncurrent liabilities							309,306	327,343			351,368
Total liabilities							7,069,688	6,117,391			6,891,168
Retained earnings							1,296,060	1,546,224			1,191,111
Total stockholders' equity	873,571		$ 932,991	872,126	$ 872,126	$ 872,126	873,571	1,236,595			932,991
Total liabilities and stockholders' equity							$ 7,943,259	$ 7,353,986			7,824,159
Statement of Stockholders' Equity [Abstract]
Beginning Balance	1,236,595		932,991	872,126	872,126	872,126
Net income (loss)	(7,874)			81,088
Other comprehensive income (loss)	(105,777)			6,864
Cumulative effect of change in adoption of leases standard				6,556
Ending Balance	873,571			932,991
Operating activities:
Net income (loss)	(7,874)			81,088
Adjustments to reconcile net income (loss) to net cash from operating activities:
Other	(9,520)			4,247
Changes in assets and liabilities:
Inventories	(86,785)			(178,405)
Other assets	26,790			(32,372)
Accrued liabilities and other	(82,191)			(2,378)
Net cash from operating activities	$ (83,216)			(194,291)
As Previously Reported
Income Statement [Abstract]
Cost of sales		$ 1,154,629	1,086,248	967,148	2,053,396	3,208,025
Gross profit		712,338	674,679	620,876	1,295,555	2,007,893
Selling, general and administrative expenses		442,582	440,662	472,838	913,500	1,356,082
Operating profit		269,756	234,017	148,038	382,055	651,811
Income before income tax expense		218,599	179,246	92,528	271,774	490,373
Net income (loss)		$ 187,776	$ 153,972	$ 79,482	$ 233,454	$ 421,230
Earnings Per Share:
Basic		$ 0.51	$ 0.42	$ 0.22	$ 0.64	$ 1.16
Diluted		$ 0.51	$ 0.42	$ 0.22	$ 0.64	$ 1.15
Other Comprehensive income (loss):
Net income (loss)		$ 187,776	$ 153,972	$ 79,482	$ 233,454	$ 421,230
Translation adjustments				14,461	11,259	(33,738)
Other comprehensive income (loss)				13,939	9,132	(30,201)
Comprehensive income		148,443	149,165	93,421	242,586	391,029
Assets
Inventories									$ 2,108,281	$ 2,233,760	2,235,809
Other current assets									166,727	152,925	166,123
Total current assets									3,625,970	3,656,442	3,621,887
Deferred tax assets									257,314	264,592	257,393
Total assets									7,773,298	7,876,892	7,848,025
Liabilities and Stockholders' Equity
Accrued liabilities									589,992	547,306	552,012
Total current liabilities									2,096,904	2,069,817	2,182,435
Other noncurrent liabilities									265,804	277,742	286,625
Total liabilities									6,543,056	6,742,042	6,809,987
Retained earnings									1,528,258	1,395,306	1,296,158
Total stockholders' equity		1,230,242	1,134,850	1,038,038	1,134,850	1,230,242			1,230,242	1,134,850	1,038,038
Total liabilities and stockholders' equity									7,773,298	7,876,892	7,848,025
Statement of Stockholders' Equity [Abstract]
Beginning Balance		1,134,850	1,038,038	970,283	970,283	970,283
Net income (loss)		187,776	153,972	79,482	233,454	421,230
Other comprehensive income (loss)				13,939	9,132	(30,201)
Cumulative effect of change in adoption of leases standard				7,977	7,977	7,977
Ending Balance		1,230,242	1,134,850	1,038,038	1,134,850	1,230,242
Operating activities:
Net income (loss)		187,776	153,972	79,482	233,454	421,230
Adjustments to reconcile net income (loss) to net cash from operating activities:
Other				11,322	12,550	8,737
Changes in assets and liabilities:
Inventories				(183,875)	(178,453)	(72,096)
Other assets				(31,629)	(27,354)	(40,732)
Accrued liabilities and other				(3,120)	(23,405)	14,243
Net cash from operating activities				(194,291)	(57,363)	244,700
Adjustments
Income Statement [Abstract]
Cost of sales		(4,695)	(844)	845	1	(4,694)
Gross profit		4,695	844	(845)	(1)	4,694
Selling, general and administrative expenses		7,380	5,261	(2,451)	2,810	10,190
Operating profit		(2,685)	(4,417)	1,606	(2,811)	(5,496)
Income before income tax expense		(2,685)	(4,417)	1,606	(2,811)	(5,496)
Net income (loss)		$ (2,685)	$ (4,417)	$ 1,606	$ (2,811)	$ (5,496)
Earnings Per Share:
Basic		$ (0.01)	$ (0.01)	$ 0	$ (0.01)	$ (0.02)
Diluted		$ (0.01)	$ (0.01)	$ 0	$ (0.01)	$ (0.02)
Other Comprehensive income (loss):
Net income (loss)		$ (2,685)	$ (4,417)	$ 1,606	$ (2,811)	$ (5,496)
Translation adjustments				(7,075)	(7,075)	(7,075)
Other comprehensive income (loss)				(7,075)	(7,075)	(7,075)
Comprehensive income		(2,685)	(4,417)	(5,469)	(9,886)	(12,571)
Assets
Inventories									(13,246)	(10,561)	(3,090)
Other current assets									7,445	23,371	22,889
Total current assets									(5,801)	12,810	19,799
Deferred tax assets									(43,665)	(43,665)	(43,665)
Total assets									(49,466)	(30,855)	(23,866)
Liabilities and Stockholders' Equity
Accrued liabilities									(2,060)	13,866	16,438
Total current liabilities									(2,060)	13,866	16,438
Other noncurrent liabilities									64,743	64,743	64,743
Total liabilities									62,683	78,609	81,181
Retained earnings									(112,149)	(109,464)	(105,047)
Total stockholders' equity		(112,149)	(109,464)	(98,157)	(109,464)	(112,149)			(112,149)	(109,464)	(105,047)
Total liabilities and stockholders' equity									(49,466)	(30,855)	(23,866)
Statement of Stockholders' Equity [Abstract]
Beginning Balance		(109,464)	(105,047)	(98,157)	(98,157)	(98,157)
Net income (loss)		(2,685)	(4,417)	1,606	(2,811)	(5,496)
Other comprehensive income (loss)				(7,075)	(7,075)	(7,075)
Cumulative effect of change in adoption of leases standard				(1,421)	(1,421)	(1,421)
Ending Balance		(112,149)	(109,464)	(105,047)	(109,464)	(112,149)
Operating activities:
Net income (loss)		(2,685)	(4,417)	1,606	(2,811)	(5,496)
Adjustments to reconcile net income (loss) to net cash from operating activities:
Other				(7,075)	(7,075)	(7,075)
Changes in assets and liabilities:
Inventories				5,470	12,941	15,626
Other assets				(743)	(1,225)	14,701
Accrued liabilities and other				742	(1,830)	(17,756)
Net cash from operating activities				0	0	0
As Revised
Income Statement [Abstract]
Cost of sales		1,149,934	1,085,404	967,993	2,053,397	3,203,331
Gross profit		717,033	675,523	620,031	1,295,554	2,012,587
Selling, general and administrative expenses		449,962	445,923	470,387	916,310	1,366,272
Operating profit		267,071	229,600	149,644	379,244	646,315
Income before income tax expense		215,914	174,829	94,134	268,963	484,877
Net income (loss)		$ 185,091	$ 149,555	$ 81,088	$ 230,643	$ 415,734
Earnings Per Share:
Basic		$ 0.51	$ 0.41	$ 0.22	$ 0.63	$ 1.14
Diluted		$ 0.51	$ 0.41	$ 0.22	$ 0.63	$ 1.14
Other Comprehensive income (loss):
Net income (loss)		$ 185,091	$ 149,555	$ 81,088	$ 230,643	$ 415,734
Translation adjustments				7,386	4,184	(40,813)
Other comprehensive income (loss)				6,864	2,057	(37,276)
Comprehensive income		145,758	144,748	87,952	232,700	378,458
Assets
Inventories									2,095,035	2,223,199	2,232,719
Other current assets									174,172	176,296	189,012
Total current assets									3,620,169	3,669,252	3,641,686
Deferred tax assets									213,649	220,927	213,728
Total assets									7,723,832	7,846,037	7,824,159
Liabilities and Stockholders' Equity
Accrued liabilities									587,932	561,172	568,450
Total current liabilities									2,094,844	2,083,683	2,198,873
Other noncurrent liabilities									330,547	342,485	351,368
Total liabilities									6,605,739	6,820,651	6,891,168
Retained earnings									1,416,109	1,285,842	1,191,111
Total stockholders' equity		1,118,093	1,025,386	932,991	1,025,386	1,118,093			1,118,093	1,025,386	932,991
Total liabilities and stockholders' equity									$ 7,723,832	$ 7,846,037	$ 7,824,159
Statement of Stockholders' Equity [Abstract]
Beginning Balance		1,025,386	932,991	872,126	872,126	872,126
Net income (loss)		185,091	149,555	81,088	230,643	415,734
Other comprehensive income (loss)				6,864	2,057	(37,276)
Cumulative effect of change in adoption of leases standard				6,556	6,556	6,556
Ending Balance		1,118,093	1,025,386	932,991	1,025,386	1,118,093
Operating activities:
Net income (loss)		$ 185,091	$ 149,555	81,088	230,643	415,734
Adjustments to reconcile net income (loss) to net cash from operating activities:
Other				4,247	5,475	1,662
Changes in assets and liabilities:
Inventories				(178,405)	(165,512)	(56,470)
Other assets				(32,372)	(28,579)	(26,031)
Accrued liabilities and other				(2,378)	(25,235)	(3,513)
Net cash from operating activities				$ (194,291)	$ (57,363)	$ 244,700